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Abstract  As the knowledge base and importance of mitochondrial physiology to human health expands, 
the necessity for harmonizing the terminology concerning mitochondrial respiratory states and rates has 
become increasingly apparent. The chemiosmotic theory establishes the mechanism of energy 
transformation and coupling in oxidative phosphorylation. The unifying concept of the protonmotive 
force provides the framework for developing a consistent theoretical foundation of mitochondrial 
physiology and bioenergetics. We follow guidelines of the International Union of Pure and Applied 
Chemistry (IUPAC) on terminology in physical chemistry, extended by considerations of open systems 
and thermodynamics of irreversible processes. The concept-driven constructive terminology 
incorporates the meaning of each quantity and aligns concepts and symbols with the nomenclature of 
classical bioenergetics. We endeavour to provide a balanced view of mitochondrial respiratory control 
and a critical discussion on reporting data of mitochondrial respiration in terms of metabolic flows and 
fluxes. Uniform standards for evaluation of respiratory states and rates will ultimately contribute to 
reproducibility between laboratories and thus support the development of databases of mitochondrial 
respiratory function in species, tissues, and cells. Clarity of concept and consistency of nomenclature 
facilitate effective transdisciplinary communication, education, and ultimately further discovery. 
 
 Keywords: Mitochondrial respiratory control, coupling control, mitochondrial preparations, 
protonmotive force, uncoupling, oxidative phosphorylation: OXPHOS, efficiency, electron transfer: ET, 
electron transfer system: ETS, proton leak, ion leak and slip compensatory state: LEAK, residual oxygen 
consumption: ROX, State 2, State 3, State 4, normalization, flow, flux, oxygen: O2 
 
Executive summary 
 
 In view of the broad implications for health care, mitochondrial researchers face an increasing 
responsibility to disseminate their fundamental knowledge and novel discoveries to a wide range of 
stakeholders and scientists beyond the group of specialists. This requires implementation of a commonly 
accepted terminology within the discipline and standardization in the translational context. Authors, 
reviewers, journal editors, and lecturers are challenged to collaborate with the aim to harmonize the 
nomenclature in the growing field of mitochondrial physiology and bioenergetics, from evolutionary 
biology and comparative physiology to mitochondrial medicine. In the present communication we focus 
on the following concepts in mitochondrial physiology: 
1. Aerobic respiration depends on the coupling of phosphorylation (ADP → ATP) to O2 flux in 
catabolic reactions. Coupling in oxidative phosphorylation is mediated by the translocation of 
protons across the mitochondrial inner membrane (mtIM) through proton pumps generating 
or utilizing the protonmotive force that is maintained between the mitochondrial matrix and 
intermembrane compartment or outer mitochondrial space. Compartmental coupling depends 
on ion translocation across a semipermeable membrane, which is defined as vectorial 
metabolism and distinguishes oxidative phosphorylation from cytosolic fermentation as 
counterparts of cellular core energy metabolism (Figure 1). Cell respiration is thus 
distinguished from fermentation: (1) Electron acceptors are supplied by external respiration 
for the maintenance of redox balance, whereas fermentation is characterized by an internal 
electron acceptor produced in intermediary metabolism. In aerobic cell respiration, redox 
balance is maintained by O2 as the electron acceptor. (2) Compartmental coupling in vectorial 
oxidative phosphorylation contrasts to exclusively scalar substrate-level phosphorylation in 
fermentation. 
2. When measuring mitochondrial metabolism, the contribution of fermentation and other cytosolic 
interactions must be excluded from analysis by disrupting the barrier function of the plasma 
membrane. Selective removal or permeabilization of the plasma membrane yields 
mitochondrial preparations—including isolated mitochondria, tissue and cellular 
preparations—with structural and functional integrity. Subsequently, extra-mitochondrial 
concentrations of fuel substrates, ADP, ATP, inorganic phosphate, and cations including H+ 
can be controlled to determine mitochondrial function under a set of conditions defined as 
coupling control states. We strive to incorporate an easily recognized and understood concept-
driven terminology of bioenergetics with explicit terms and symbols that define the nature of 
respiratory states. 
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3. Mitochondrial coupling states are defined according to the control of respiratory oxygen flux by 
the protonmotive force. Capacities of oxidative phosphorylation and electron transfer are 
measured at kinetically-saturating concentrations of fuel substrates, ADP and inorganic 
phosphate, and O2, or at optimal uncoupler concentrations, respectively, in the absence of 
Complex IV inhibitors such as NO, CO, or H2S. Respiratory capacity is a measure of the upper 
boundary of the rate of respiration; it depends on the substrate type undergoing oxidation, and 
provides reference values for the diagnosis of health and disease, and for evaluation of the 
effects of Evolutionary background, Age, Gender and sex, Lifestyle and Environment. 
 
Figure 1. Internal and external respiration 
Mitochondrial respiration is the oxidation of fuel 
substrates (electron donors) and reduction of O2 
catalysed by the electron transfer system, ETS: 
(mt) mitochondrial catabolic respiration; (ce) 
total cellular O2 consumption; and (ext) external 
respiration. All chemical reactions, r, that 
consume O2 in the cells of an organism, 
contribute to cell respiration, JrO2. In addition to 
mitochondrial catabolic respiration, O2 is 
consumed by:  
 Mitochondrial residual oxygen consumption, 
Rox.  Non-mitochondrial O2 consumption by 
catabolic reactions, particularly peroxisomal 
oxidases and microsomal cytochrome P450 
systems.  Non-mitochondrial Rox by reactions 
unrelated to catabolism.   Extracellular Rox.  
Aerobic microbial respiration. Bars are not at a 
quantitative scale. 
(mt) Mitochondrial catabolic respiration, JkO2, 
is the O2 consumption by the mitochondrial 
ETS excluding Rox. 
(ce) Cell respiration, JrO2, takes into account 
internal O2-consuming reactions, r, including catabolic respiration and Rox. Catabolic cell respiration 
is the O2 consumption associated with catabolic pathways in the cell, including mitochondrial 
catabolism in addition to peroxisomal and microsomal oxidation reactions (). 
(ext) External respiration balances internal respiration at steady-state, including extracellular Rox () 
and aerobic respiration by the microbiome (). O2 is transported from the environment across the 
respiratory cascade, i.e., circulation between tissues and diffusion across cell membranes, to the 
intracellular compartment. The respiratory quotient, RQ, is the molar CO2/O2 exchange ratio; when 
combined with the respiratory nitrogen quotient, N/O2 (mol N given off per mol O2 consumed), the 
RQ reflects the proportion of carbohydrate, lipid and protein utilized in cell respiration during 
aerobically balanced steady-states. Bicarbonate and CO2 are transported in reverse to the 
extracellular mileu and the organismic environment. Hemoglobin provides the molecular paradigm 
for the combination of O2 and CO2 exchange, as do lungs and gills on the morphological level. 
Consult Table 8 for a list of terms and symbols. 
 
4. Incomplete tightness of coupling, i.e., some degree of uncoupling relative to the substrate-
dependent coupling stoichiometry, is a characteristic of energy-transformations across 
membranes. Uncoupling is caused by a variety of physiological, pathological, toxicological, 
pharmacological and environmental conditions that exert an influence not only on the proton 
leak and cation cycling, but also on proton slip within the proton pumps and the structural 
integrity of the mitochondria. A more loosely coupled state is induced by stimulation of 
mitochondrial superoxide formation and the bypass of proton pumps. In addition, the use of 
protonophores represents an experimental uncoupling intervention to assess the transition 
from a well-coupled to a noncoupled state of mitochondrial respiration. 
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5. Respiratory oxygen consumption rates have to be carefully normalized to enable meta-analytic 
studies beyond the question of a particular experiment. Therefore, all raw data on rates and 
variables for normalization should be published in an open access data repository. 
Normalization of rates for: (1) the number of objects (cells, organisms); (2) the volume or 
mass of the experimental sample; and (3) the concentration of mitochondrial markers in the 
experimental chamber are sample-specific normalizations, which are distinguished from 
system-specific normalization for the volume of the chamber (the measuring system). 
6. The consistent use of terms and symbols will facilitate transdisciplinary communication and 
support the further development of a collaborative database on bioenergetics and 
mitochondrial physiology. The present considerations are focused on studies with 
mitochondrial preparations. These will be extended in a series of reports on pathway control 
of mitochondrial respiration, respiratory states in intact cells, and harmonization of 
experimental procedures. 
 
Box 1: In brief – Mitochondria and Bioblasts 
‘For the physiologist, mitochondria afforded the first opportunity for an experimental 
approach to structure-function relationships, in particular those involved in active 
transport, vectorial metabolism, and metabolic control mechanisms on a subcellular level’ 
(Ernster and Schatz 1981). 
Mitochondria are oxygen-consuming electrochemical generators that evolved from the endosymbiotic 
alphaproteobacteria which became integrated into a host cell related to Asgard Archaea (Margulis 1970; 
Lane 2005; Roger et al. 2017). They were described by Richard Altmann (1894) as ‘bioblasts’, which 
include not only the mitochondria as presently defined, but also symbiotic and free-living bacteria. The 
word ‘mitochondria’ (Greek mitos: thread; chondros: granule) was introduced by Carl Benda (1898). 
Mitochondrion is singular and mitochondria is plural. Abbreviation: mt, as generally used in mtDNA. 
 Contrary to current textbook dogma, which describes mitochondria as individual organelles, 
mitochondria form dynamic networks within eukaryotic cells. Mitochondrial movement is supported by 
microtubules and morphology can change in response to energy requirements of the cell via processes 
known as fusion and fission; these interactions allow mitochondria to communicate within a network 
(Chan 2006). Mitochondria can even traverse cell boundaries in a process known as horizontal 
mitochondrial transfer (Torralba et al. 2016). Another defining characteristic of mitochondria is the 
double membrane. The mitochondrial inner membrane (mtIM) forms dynamic tubular to disk-shaped 
cristae that separate the mitochondrial matrix, i.e., the negatively charged internal mitochondrial 
compartment, from the intermembrane space; the latter being enclosed by the mitochondrial outer 
membrane (mtOM) and positively charged with respect to the matrix.  
 The mtIM contains the non-bilayer phospholipid cardiolipin, which is also involved in the mtOM 
(Gebert et al. 2009) but is not present in any other eukaryotic cellular membrane. Cardiolipin has many 
regulatory functions (Oemer et al. 2018); it promotes and stabilizes the formation of supercomplexes 
(SC InIIInIVn) based on dynamic interactions between specific respiratory complexes (McKenzie et al. 
2006; Greggio et al. 2017; Lenaz et al. 2017), and it supports proton transfer on the mtIM from the 
electron transfer system to F-ATPase (ATP synthase; Yoshinaga et al. 2016). The mtIM is plastic and 
exerts an influence on the functional properties of incorporated proteins (Waczulikova et al. 2007). 
Intracellular stress factors may cause shrinking or swelling of the mitochondrial matrix that can 
ultimately result in permeability transition (mtPT; Lemasters et al. 1998). 
 Mitochondria constitute the structural and functional elementary components of cell respiration. 
Mitochondrial respiration is the reduction of molecular oxygen by electron transfer coupled to 
electrochemical proton translocation across the mtIM. In the process of oxidative phosphorylation 
(OXPHOS), the catabolic reaction of oxygen consumption is electrochemically coupled to the 
transformation of energy in the form of adenosine triphosphate (ATP; Mitchell 1961, 2011). 
Mitochondria are the powerhouses of the cell that contain the machinery of the OXPHOS-pathways, 
including transmembrane respiratory complexes (proton pumps with FMN, Fe-S and cytochrome b, c, 
aa3 redox systems); alternative dehydrogenases and oxidases; the coenzyme ubiquinone (Q); F-ATPase 
or ATP synthase; the enzymes of the tricarboxylic acid cycle (TCA), fatty acid and amino acid oxidation; 
transporters of ions, metabolites and co-factors; iron/sulphur cluster synthesis; and mitochondrial 
kinases related to catabolic pathways. The mitochondrial proteome comprises over 1,200 proteins 
(Calvo et al. 2015; 2017), mostly encoded by nuclear DNA (nDNA), with a variety of functions, many 
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of which are relatively well known, e.g., proteins regulating mitochondrial biogenesis or apoptosis, 
while others are still under investigation, or need to be identified, e.g., mtPT pore, alanine transporter. 
The mammalian mitochondrial proteome can be used to discover and characterize the genetic basis of 
mitochondrial diseases (Williams et al. 2016; Palmfeldt and Bross 2017). 
 Numerous cellular processes are orchestrated by a constant crosstalk between mitochondria and 
other cellular components. For example, the crosstalk between mitochondria and the endoplasmic 
reticulum is involved in the regulation of calcium homeostasis, cell division, autophagy, differentiation, 
and anti-viral signaling (Murley and Nunnari 2016). Mitochondria contribute to the formation of 
peroxisomes, which are hybrids of mitochondrial and ER-derived precursors (Sugiura et al. 2017). 
Cellular mitochondrial homeostasis (mitostasis) is maintained through regulation at transcriptional, 
post-translational and epigenetic levels, resulting in dynamic regulation of mitochondrial turnover by 
biogenesis of new mitochondria and removal of damaged mitochondria by fusion, fission and mitophagy 
(Singh et al. 2018). Cell signalling modules contribute to homeostatic regulation throughout the cell 
cycle or even cell death by activating proteostatic modules, e.g., the ubiquitin-proteasome and 
autophagy-lysosome/vacuole pathways; specific proteases like LON, and genome stability modules in 
response to varying energy demands and stress cues (Quiros et al. 2016). Several post-translational 
modifications, including acetylation and nitrosylation, are also capable of influencing the bioenergetic 
response, with clinically significant implications for health and disease (Carrico et al. 2018). 
 Mitochondria of higher eukaryotes typically maintain several copies of their own circular genome 
known as mitochondrial DNA (mtDNA; hundred to thousands per cell; Cummins 1998), which is 
maternally inherited in many species. However, biparental mitochondrial inheritance is documented in 
some exceptional cases in humans (Luo et al. 2018), is widespread in birds, fish, reptiles and invertebrate 
groups, and is even the norm in some bivalve taxonomic groups (Breton et al. 2007; White et al. 2008). 
The mitochondrial genome of the angiosperm Amborella contains a record of six mitochondrial genome 
equivalents acquired by horizontal transfer of entire genomes, two from angiosperms, three from algae 
and one from mosses (Rice et al. 2016). In unicellular organisms, i.e., protists, the structural organization 
of mitochondrial genomes is highly variable and includes circular and linear DNA (Zikova et al. 2016). 
While some of the free-living flagellates exhibit the largest known gene coding capacity, e.g., jakobid 
Andalucia godoyi mitochondrial DNA codes for 106 genes (Burger et al. 2013), some protist groups, 
e.g., alveolates, possess mitochondrial genomes with only three protein-coding genes and two rRNAs 
(Feagin et al. 2012). The complete loss of mitochondrial genome is observed in the highly reduced 
mitochondria of Cryptosporidium species (Liu et al. 2016). Reaching the final extreme, the microbial 
eukaryote, oxymonad Monocercomonoides, has no mitochondrion whatsoever and lacks all typical 
nuclear-encoded mitochondrial proteins, showing that while in 99% of organisms mitochondria play a 
vital role, this organelle is not indispensable (Karnkowska et al. 2016). 
 In vertebrates, but not all invertebrates, mtDNA is compact (16.5 kB in humans) and encodes 13 
protein subunits of the transmembrane respiratory Complexes CI, CIII, CIV and ATP synthase (F-
ATPase), 22 tRNAs, and two ribosomal RNAs. Additional gene content has been suggested to include 
microRNAs, piRNA, smithRNAs, repeat associated RNA, long noncoding RNAs, and even additional 
proteins or peptides (Rackham et al. 2011; Duarte et al. 2014; Lee et al. 2015; Cobb et al. 2016). The 
mitochondrial genome requires nuclear-encoded mitochondrially targeted proteins, e.g., TFAM, for its 
maintenance and expression (Rackham et al. 2012). The nuclear and the mitochondrial genomes encode 
peptides of the membrane spanning redox pumps (CI, CIII and CIV) and F-ATPase, leading to strong 
constraints in the coevolution of both genomes (Blier et al. 2001). 
 Given the multiple roles of mitochondria, it is perhaps not surprising that mitochondrial 
dysfunction is associated with a wide variety of genetic and degenerative diseases. Robust mitochondrial 
function is supported by physical exercise and caloric balance, and is central for sustained metabolic 
health throughout life. Therefore, a more consistent set of definitions for mitochondrial physiology will 
increase our understanding of the etiology of disease and improve the diagnostic repertoire of 
mitochondrial medicine with a focus on protective medicine, lifestyle and healthy aging. 
 
 
1. Introduction 
 
 Mitochondria are the powerhouses of the cell with numerous physiological, molecular, and 
genetic functions (Box 1). Every study of mitochondrial health and disease faces Evolution, Age, 
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Gender and sex, Lifestyle, and Environment (MitoEAGLE) as essential background conditions intrinsic 
to the individual person or cohort, species, tissue and to some extent even cell line. As a large and 
coordinated group of laboratories and researchers, the mission of the global MitoEAGLE Network is to 
generate the necessary scale, type, and quality of consistent data sets and conditions to address this 
intrinsic complexity. Harmonization of experimental protocols and implementation of a quality control 
and data management system are required to interrelate results gathered across a spectrum of studies 
and to generate a rigorously monitored database focused on mitochondrial respiratory function. In this 
way, researchers from a variety of disciplines can compare their findings using clearly defined and 
accepted international standards. 
 With an emphasis on quality of research, published data can be useful far beyond the specific 
question of a particular experiment. For example, collaborative data sets support the development of 
open-access databases such as those for National Institutes of Health sponsored research in genetics, 
proteomics, and metabolomics. Indeed, enabling meta-analysis is the most economic way of providing 
robust answers to biological questions (Cooper et al. 2009). However, the reproducibility of quantitative 
results and databases depend on accurate measurements under strictly-defined conditions. Likewise, 
meaningful interpretation and comparability of experimental outcomes requires standardisation of 
protocols between research groups at different institutes. In addition to quality control, a conceptual 
framework is also required to standardise and harmonise terminology and methodology. Vague or 
ambiguous jargon can lead to confusion and may convert valuable signals to wasteful noise. For this 
reason, measured values must be expressed in standard units for each parameter used to define 
mitochondrial respiratory function. A consensus on fundamental nomenclature and conceptual 
coherence, however, are missing in the expanding field of mitochondrial physiology. To fill this gap, 
the present communication provides an in-depth review on harmonization of nomenclature and 
definition of technical terms, which are essential to improve the awareness of the intricate meaning of 
current and past scientific vocabulary. This is important for documentation and integration into 
databases in general, and quantitative modelling in particular (Beard 2005).  
 In this review, we focus on coupling states and fluxes through metabolic pathways of aerobic 
energy transformation in mitochondrial preparations as a first step in the attempt to generate a 
conceptually-oriented nomenclature in bioenergetics and mitochondrial physiology. Respiratory control 
by fuel substrates and specific inhibitors of respiratory enzymes, coupling states of intact cells, and 
respiratory flux control ratios will be reviewed in subsequent communications, prepared in the frame of 
the EU COST Action MitoEAGLE open to global bottom-up input. 
 
2. Coupling states and rates in mitochondrial preparations 
‘Every professional group develops its own technical jargon for talking about matters of critical 
concern ... People who know a word can share that idea with other members of their group, and 
a shared vocabulary is part of the glue that holds people together and allows them to create a 
shared culture’ (Miller 1991). 
 
2.1. Cellular and mitochondrial respiration 
 
 2.1.1. Aerobic and anaerobic catabolism and ATP turnover: In respiration, electron transfer 
is coupled to the phosphorylation of ADP to ATP, with energy transformation mediated by the 
protonmotive force, pmf (Figure 2). Anabolic reactions are coupled to catabolism, both by ATP as the 
intermediary energy currency and by small organic precursor molecules as building blocks for 
biosynthesis. Glycolysis involves substrate-level phosphorylation of ADP to ATP in fermentation 
without utilization of O2, studied mainly in intact cells and organisms. Many cellular fuel substrates are 
catabolized to acetyl-CoA or to glutamate, and further electron transfer reduces nicotinamide adenine 
dinucleotide to NADH or flavin adenine dinucleotide to FADH2. Subsequent mitochondrial electron 
transfer to O2 is coupled to proton translocation for the control of the protonmotive force and 
phosphorylation of ADP (Figure 2B and 2C). In contrast, extra-mitochondrial oxidation of fatty acids 
and amino acids proceeds partially in peroxisomes without coupling to ATP production: acyl-CoA 
oxidase catalyzes the oxidation of FADH2 with electron transfer to O2; amino acid oxidases oxidize 
flavin mononucleotide FMNH2 or FADH2 (Figure 2A). 
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Figure 2. Cell respiration and oxidative phosphorylation (OXPHOS) 
Mitochondrial respiration is the oxidation of fuel substrates (electron donors) with electron 
transfer to O2 as the electron acceptor. For explanation of symbols see also Figure 1.  
(A) Respiration of intact cells: Extra-mitochondrial catabolism of macrofuels and uptake 
of small molecules by the cell provide the mitochondrial fuel substrates. Dashed arrows 
indicate the connection between the redox proton pumps (respiratory Complexes CI, CIII 
and CIV) and the transmembrane protonmotive force, pmf. Coenzyme Q (Q) and the 
cytochromes b, c, and aa3 are redox systems of the mitochondrial inner membrane, mtIM. 
Glycerol-3-phosphate, Gp. 
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(B) Respiration in mitochondrial preparations: The mitochondrial electron transfer system 
(ETS) is (1) fuelled by diffusion and transport of substrates across the mtOM and mtIM, 
and in addition consists of the (2) matrix-ETS, and (3) membrane-ETS. Electron transfer 
converges at the N-junction, and from CI, CII and electron transferring flavoprotein 
complex (CETF) at the Q-junction. Unlabeled arrows converging at the Q-junction indicate 
additional ETS-sections with electron entry into Q through glycerophosphate 
dehydrogenase, dihydroorotate dehydrogenase, proline dehydrogenase, choline 
dehydrogenase, and sulfide-ubiquinone oxidoreductase. The dotted arrow indicates the 
branched pathway of oxygen consumption by alternative quinol oxidase (AOX). ET-
pathways are coupled to the phosphorylation-pathway. The H+pos/O2 ratio is the outward 
proton flux from the matrix space to the positively (pos) charged vesicular compartment, 
divided by catabolic O2 flux in the NADH-pathway. The H+neg/P» ratio is the inward proton 
flux from the inter-membrane space to the negatively (neg) charged matrix space, divided 
by the flux of phosphorylation of ADP to ATP. These stoichiometries are not fixed because 
of ion leaks and proton slip. Modified from Lemieux et al. (2017) and Rich (2013). 
(C) OXPHOS coupling: O2 flux through the catabolic ET-pathway, JkO2, is coupled 
by the H+ circuit to flux through the phosphorylation-pathway of ADP to ATP, JP». 
(D) Phosphorylation-pathway catalyzed by the proton pump F1FO-ATPase (F-ATPase, 
ATP synthase), adenine nucleotide translocase (ANT), and inorganic phosphate carrier 
(PiC). The H+neg/P» stoichiometry is the sum of the coupling stoichiometry in the F-ATPase 
reaction (-2.7 H+pos from the positive intermembrane space, 2.7 H+neg to the matrix, i.e., the 
negative compartment) and the proton balance in the translocation of ADP3-, ATP4- and Pi2- 
(negative for substrates). Modified from Gnaiger (2014). 
 
 The plasma membrane separates the intracellular compartment including the cytosol, nucleus, and 
organelles from the extracellular environment. The plasma membrane consists of a lipid bilayer with 
embedded proteins and attached organic molecules that collectively control the selective permeability 
of ions, organic molecules, and particles across the cell boundary. The intact plasma membrane prevents 
the passage of many water-soluble mitochondrial substrates and inorganic ions—such as succinate, 
adenosine diphosphate (ADP) and inorganic phosphate (Pi) that must be precisely controlled at 
kinetically-saturating concentrations for the analysis of mitochondrial respiratory capacities. 
Respiratory capacities delineate, comparable to channel capacity in information theory (Schneider 
2006), the upper boundary of the rate of O2 consumption measured in defined respiratory states. Despite 
the activity of solute carriers, e.g., the sodium-dependent dicarboxylate transporter SLC13A3 and the 
sodium-dependent phosphate transporter SLC20A2, which transport specific metabolites across the 
plasma membrane of various cell types, the intact plasma membrane limits the scope of investigations 
into mitochondrial respiratory function in intact cells. 
 2.1.2. Specification of biochemical dose: Substrates, uncouplers, inhibitors, and other chemical 
reagents are titrated to analyse cellular and mitochondrial function. Nominal concentrations of these 
substances are usually reported as initial amount of substance concentration [mol∙L-1] in the incubation 
medium. Kinetically-saturating conditions are evaluated by substrate kinetics to obtain the maximum 
reaction velocity or maximum pathway flux, in contrast to solubility-saturated conditions. When aiming 
at the measurement of kinetically-saturated processes—such as OXPHOS-capacities—the 
concentrations for substrates can be chosen according to the Michaelis constant, Km, or half-saturating 
substrate concentration, c50. In the case of hyperbolic kinetics, only 80% of maximum respiratory 
capacity is obtained at a substrate concentration of four times the c50, whereas substrate concentrations 
of 5, 9, 19 and 49 times the c50 are theoretically required for reaching 83%, 90%, 95% or 98% of the 
maximal rate (Gnaiger 2001). Other reagents are chosen to inhibit or alter a particular process. The 
amount of these chemicals in an experimental incubation is selected to maximize effect, avoiding 
unacceptable off-target consequences that would adversely affect the data being sought. Specifying the 
amount of substance in an incubation as nominal concentration in the aqueous incubation medium can 
be ambiguous (Doskey et al. 2015), particularly for cations (TPP+; fluorescent dyes such as safranin, 
TMRM; Chowdhury et al. 2015) and lipophilic substances (oligomycin, uncouplers, permeabilization 
agents; Doerrier et al. 2018), which accumulate in the mitochondrial matrix or in biological membranes, 
respectively. Generally, dose/exposure can be specified per unit of biological sample, i.e., (nominal 
moles of xenobiotic)/(number of cells) [mol∙cell-1] or, as appropriate, per mass of biological sample 
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[mol∙kg-1]. This approach to specification of dose/exposure provides a scalable parameter that can be 
used to design experiments, help interpret a wide variety of experimental results, and provide absolute 
information that allows researchers worldwide to make the most use of published data (Doskey et al. 
2015).  
 
2.2. Mitochondrial preparations 
 
 Mitochondrial preparations are defined as either isolated mitochondria or tissue and cellular 
preparations in which the barrier function of the plasma membrane is disrupted. Since this entails the 
loss of cell viability, mitochondrial preparations are not studied in vivo. In contrast to isolated 
mitochondria and tissue homogenate preparations, mitochondria in permeabilized tissues and cells are 
in situ relative to the plasma membrane. When studying mitochondrial preparations, substrate-
uncoupler-inhibitor-titration (SUIT) protocols are used to establish respiratory coupling control states 
(CCS) and pathway control states (PCS) that provide reference values for various output variables 
(Table 1). Physiological conditions in vivo deviate from these experimentally obtained states; this is 
because kinetically-saturating concentrations, e.g., of ADP, oxygen (O2; dioxygen) or fuel substrates, 
may not apply to physiological intracellular conditions. Further information is obtained in studies of 
kinetic responses to variations in fuel substrate concentrations, [ADP], or [O2] in the range between 
kinetically-saturating concentrations and anoxia (Gnaiger 2001). 
 The cholesterol content of the plasma membrane is high compared to mitochondrial membranes 
(Korn 1969). Therefore, mild detergents—such as digitonin and saponin—can be applied to selectively 
permeabilize the plasma membrane via interaction with cholesterol; this allows free exchange of organic 
molecules and inorganic ions between the cytosol and the immediate cell environment, while 
maintaining the integrity and localization of organelles, cytoskeleton, and the nucleus. Application of 
permeabilization agents (mild detergents or toxins) leads to washout of cytosolic marker enzymes—
such as lactate dehydrogenase—and results in the complete loss of cell viability (tested by nuclear 
staining using plasma membrane-impermeable dyes), while mitochondrial function remains intact 
(tested by cytochrome c stimulation of respiration). Digitonin concentrations have to be optimized 
according to cell type, particularly since mitochondria from cancer cells contain significantly higher 
contents of cholesterol in both membranes (Baggetto and Testa-Perussini, 1990). For example, a dose 
of digitonin of 8 fmol∙cell-1 (10 pg∙cell-1; 10 µg∙10-6 cells) is optimal for permeabilization of endothelial 
cells, and the concentration in the incubation medium has to be adjusted according to the cell density 
(Doerrier et al. 2018). Respiration of isolated mitochondria remains unaltered after the addition of low 
concentrations of digitonin or saponin. In addition to mechanical cell disruption during homogenization 
of tissue, permeabilization agents may be applied to ensure permeabilization of all cells in tissue 
homogenates. 
 Suspensions of cells permeabilized in the respiration chamber and crude tissue homogenates 
contain all components of the cell at highly dilute concentrations. All mitochondria are retained in 
chemically-permeabilized mitochondrial preparations and crude tissue homogenates. In the preparation 
of isolated mitochondria, however, the mitochondria are separated from other cell fractions and purified 
by differential centrifugation, entailing the loss of mitochondria at typical recoveries ranging from 30% 
to 80% of total mitochondrial content (Lai et al. 2018). Using Percoll or sucrose density gradients to 
maximize the purity of isolated mitochondria may compromise the mitochondrial yield or structural and 
functional integrity. Therefore, mitochondrial isolation protocols need to be optimized according to each 
study. The term, mitochondrial preparation, neither includes intact cells, nor submitochondrial particles 
and further fractionated mitochondrial components. 
 
2.3. Electron transfer pathways 
 
 Mitochondrial electron transfer (ET) pathways are fuelled by diffusion and transport of substrates 
across the mtOM and mtIM. In addition, the mitochondrial electron transfer system (ETS) consists of 
the matrix-ETS and membrane-ETS (Figure 2B). Upstream sections of ET-pathways converge at the 
NADH-junction (N-junction). NADH is mainly generated in the tricarboxylic acid (TCA) cycle and is 
oxidized by Complex I (CI), with further electron entry into the coenzyme Q-junction (Q-junction). 
Similarly, succinate is formed in the TCA cycle and oxidized by CII to fumarate. CII is part of both the 
TCA cycle and the ETS, and reduces FAD to FADH2 with further reduction of ubiquinone to ubiquinol 
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downstream of the TCA cycle in the Q-junction. Thus FADH2 is not a substrate but is the product of 
CII, in contrast to erroneous metabolic maps shown in many publications. β-oxidation of fatty acids 
(FA) supplies reducing equivalents via (1) FADH2 as the substrate of electron transferring flavoprotein 
complex (CETF); (2) acetyl-CoA generated by chain shortening; and (3) NADH generated via 3-
hydroxyacyl-CoA dehydrogenases. The ATP yield depends on whether acetyl-CoA enters the TCA 
cycle, or is for example used in ketogenesis. 
 Selected mitochondrial catabolic pathways, k, of electron transfer from the oxidation of fuel 
substrates to the reduction of O2 are activated by addition of fuel substrates to the mitochondrial 
respiration medium after depletion of endogenous substrates (Figure 2B). Substrate combinations and 
specific inhibitors of ET-pathway enzymes are used to obtain defined pathway control states in 
mitochondrial preparations (Gnaiger 2014). 
 
2.4. Respiratory coupling control 
 
 2.4.1. Coupling: In mitochondrial electron transfer, vectorial transmembrane proton flux is 
coupled through the redox proton pumps CI, CIII and CIV to the catabolic flux of scalar reactions, 
collectively measured as O2 flux, JkO2 (Figure 2). Thus mitochondria are elementary components of 
energy transformation. Energy is a conserved quantity and cannot be lost or produced in any internal 
process (First Law of Thermodynamics). Open and closed systems can gain or lose energy only by 
external fluxes—by exchange with the environment. Therefore, energy can neither be produced by 
mitochondria, nor is there any internal process without energy conservation. Exergy or Gibbs energy 
(‘free energy’) is the part of energy that can potentially be transformed into work under conditions of 
constant temperature and pressure. Coupling is the interaction of an exergonic process (spontaneous, 
negative exergy change) with an endergonic process (positive exergy change) in energy transformations 
which conserve part of the exergy that would be irreversibly lost or dissipated in an uncoupled process. 
 Pathway control states (PCS) and coupling control states (CCS) are complementary, since 
mitochondrial preparations depend on (1) an exogenous supply of pathway-specific fuel substrates and 
oxygen, and (2) exogenous control of phosphorylation (Figure 2). 
 2.4.2. Phosphorylation, P», and P»/O2 ratio: Phosphorylation in the context of OXPHOS is 
defined as phosphorylation of ADP by Pi to form ATP. On the other hand, the term phosphorylation is 
used generally in many contexts, e.g., protein phosphorylation. This justifies consideration of a symbol 
more discriminating and specific than P as used in the P/O ratio (phosphate to atomic oxygen ratio), 
where P indicates phosphorylation of ADP to ATP or GDP to GTP (Figure 2). We propose the symbol 
P» for the endergonic (uphill) direction of phosphorylation ADP→ATP, and likewise the symbol P« for 
the corresponding exergonic (downhill) hydrolysis ATP→ADP. P» refers mainly to electrontransfer 
phosphorylation but may also involve substrate-level phosphorylation as part of the TCA cycle 
(succinyl-CoA ligase, phosphoglycerate kinase) and phosphorylation of ADP catalyzed by pyruvate 
kinase, and of GDP phosphorylated by phosphoenolpyruvate carboxykinase. Transphosphorylation is 
performed by adenylate kinase, creatine kinase (mtCK), hexokinase and nucleoside diphosphate kinase. 
In isolated mammalian mitochondria, ATP production catalyzed by adenylate kinase (2 ADP ↔ ATP + 
AMP) proceeds without fuel substrates in the presence of ADP (Komlódi and Tretter 2017). Kinase 
cycles are involved in intracellular energy transfer and signal transduction for regulation of energy flux. 
 The P»/O2 ratio (P»/4 e-) is two times the ‘P/O’ ratio (P»/2 e-). P»/O2 is a generalized symbol, not 
specific for reporting Pi consumption (Pi/O2 flux ratio), ADP depletion (ADP/O2 flux ratio), or ATP 
production (ATP/O2 flux ratio). The mechanistic P»/O2 ratio—or P»/O2 stoichiometry—is calculated 
from the proton–to–O2 and proton–to–phosphorylation coupling stoichiometries (Figure 2B): 
 
  P»/O2  =   
Hpos
+ /O2
Hneg
+ /P»
 (1) 
 
The H+pos/O2 coupling stoichiometry (referring to the full four electron reduction of O2) depends on the 
relative involvement of the three coupling sites (respiratory Complexes CI, CIII and CIV) in the 
catabolic ET-pathway from reduced fuel substrates (electron donors) to the reduction of O2 (electron 
acceptor). This varies with: (1) a bypass of CI by single or multiple electron input into the Q-junction; 
and (2) a bypass of CIV by involvement of alternative oxidases, AOX. AOX are expressed in all plants, 
some fungi, many protists, and several animal phyla, but are not expressed in vertebrate mitochondria 
(McDonald et al. 2009). 
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 The H+pos/O2 coupling stoichiometry equals 12 in the ET-pathways involving CIII and CIV as 
proton pumps, increasing to 20 for the NADH-pathway through CI (Figure 2B), but a general consensus 
on H+pos/O2 stoichiometries remains to be reached (Hinkle 2005; Wikström and Hummer 2012; Sazanov 
2015). The H+neg/P» coupling stoichiometry (3.7; Figure 2B) is the sum of 2.7 H+neg required by the F-
ATPase of vertebrate and most invertebrate species (Watt et al. 2010) and the proton balance in the 
translocation of ADP, ATP and Pi (Figure 2C). Taken together, the mechanistic P»/O2 ratio is calculated 
at 5.4 and 3.3 for NADH- and succinate-linked respiration, respectively (Eq. 1). The corresponding 
classical P»/O ratios (referring to the 2 electron reduction of 0.5 O2) are 2.7 and 1.6 (Watt et al. 2010), 
in agreement with the measured P»/O ratio for succinate of 1.58 ± 0.02 (Gnaiger et al. 2000). 
 2.4.3. Uncoupling: The effective P»/O2 flux ratio (YP»/O2 = JP»/JkO2) is diminished relative to the 
mechanistic P»/O2 ratio by intrinsic and extrinsic uncoupling or dyscoupling (Figure 3). Such 
generalized uncoupling is different from switching to mitochondrial pathways that involve fewer than 
three proton pumps (‘coupling sites’: Complexes CI, CIII and CIV), bypassing CI through multiple 
electron entries into the Q-junction, or CIII and CIV through AOX (Figure 2B). Reprogramming of 
mitochondrial pathways leading to different types of substrates being oxidized may be considered as a 
switch of gears (changing the stoichiometry by altering the substrate that is oxidized) rather than 
uncoupling (loosening the tightness of coupling relative to a fixed stoichiometry). In addition, YP»/O2 
depends on several experimental conditions of flux control, increasing as a hyperbolic function of [ADP] 
to a maximum value (Gnaiger 2001). 
 
Figure 3. Mechanisms of respiratory uncoupling 
An intact mitochondrial inner membrane, mtIM, is required for vectorial, compartmental coupling. 
‘Acoupled’ respiration is the consequence of structural disruption with catalytic activity of non-
compartmental mitochondrial fragments. Inducible uncoupling, e.g., by activation of UCP1, increases 
LEAK-respiration; experimentally noncoupled respiration provides an estimate of ET-capacity obtained 
by titration of protonophores stimulating respiration to maximum O2 flux. H+ leak-uncoupled, 
decoupled, and loosely coupled respiration are components of intrinsic uncoupling (Table 2). 
Pathological dysfunction may affect all types of uncoupling, including permeability transition (mtPT), 
causing intrinsically dyscoupled respiration. Similarly, toxicological and environmental stress factors 
can cause extrinsically dyscoupled respiration. Reduced fuel substrates, red; oxidized products, ox. 
 
 Uncoupling of mitochondrial respiration is a general term comprising diverse mechanisms: 
 1.  Proton leak across the mtIM from the positive to the negative compartment (H+ leak-uncoupled; 
Figure 3). 
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 2.  Cycling of other cations, strongly stimulated by mtPT; comparable to the use of protonophores, 
cation cycling is experimentally induced by valinomycin in the presence of K+; 
 3.  Decoupling by proton slip in the redox proton pumps when protons are effectively not pumped 
(CI, CIII and CIV) or are not driving phosphorylation (F-ATPase);  
 4.  Loss of vesicular (compartmental) integrity when electron transfer is acoupled; 
 5.  Electron leak in the loosely coupled univalent reduction of O2 to superoxide (O2•–; superoxide 
anion radical). 
Differences of terms—uncoupled vs. noncoupled—are easily overlooked, although they relate to 
different meanings of uncoupling (Figure 3 and Table 2). 
 
2.5. Coupling states and respiratory rates 
 
 To extend the classical nomenclature on mitochondrial coupling states (Section 2.6) by a concept-
driven terminology that explicitly incorporates information on the meaning of respiratory states, the 
terminology must be general and not restricted to any particular experimental protocol or mitochondrial 
preparation (Gnaiger 2009). Concept-driven nomenclature aims at mapping the meaning and concept 
behind the words and acronyms onto the forms of words and acronyms (Miller 1991). The focus of 
concept-driven nomenclature is primarily the conceptual why, along with clarification of the 
experimental how. 
 
Table 1. Coupling states and residual oxygen consumption in mitochondrial 
preparations in relation to respiration- and phosphorylation-flux, JkO2 and JP», and 
protonmotive force, pmf. Coupling states are established at kinetically-saturating 
concentrations of fuel substrates and O2. 
State JkO2 JP» pmf Inducing factors Limiting factors 
LEAK L; low, cation leak-
dependent 
respiration  
0 max. back-flux of cations 
including proton 
leak, proton slip  
JP» = 0: (1) without ADP, 
L(n); (2) max. ATP/ADP 
ratio, L(T); or (3) 
inhibition of the 
phosphorylation-
pathway, L(Omy) 
OXPHOS P; high, ADP-
stimulated 
respiration, 
OXPHOS-capacity 
max. high  kinetically-
saturating [ADP] 
and [Pi] 
JP» by phosphorylation-
pathway capacity; or JkO2 
by ET-capacity 
ET E; max., 
noncoupled 
respiration,  
ET-capacity 
0 low  optimal external 
uncoupler 
concentration for 
max. JO2,E 
JkO2 by ET-capacity 
ROX Rox; min., residual 
O2 consumption 
0 0 JO2,Rox in non-ET-
pathway oxidation 
reactions 
inhibition of all ET-
pathways; or absence of 
fuel substrates 
 
 To provide a diagnostic reference for respiratory capacities of core energy metabolism, the 
capacity of oxidative phosphorylation, OXPHOS, is measured at kinetically-saturating concentrations 
of ADP and Pi. The oxidative ET-capacity reveals the limitation of OXPHOS-capacity mediated by the 
phosphorylation-pathway. The ET- and phosphorylation-pathways comprise coupled segments of the 
OXPHOS-system. By application of external uncouplers, ET-capacity is measured as noncoupled 
respiration. The contribution of intrinsically uncoupled O2 consumption is studied by preventing the 
stimulation of phosphorylation either in the absence of ADP or by inhibition of the phosphorylation-
pathway. The corresponding states are collectively classified as LEAK-states when O2 consumption 
compensates mainly for ion leaks, including the proton leak. Defined coupling states are induced by: (1) 
adding cation chelators such as EGTA, binding free Ca2+ and thus limiting cation cycling; (2) adding 
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ADP and Pi; (3) inhibiting the phosphorylation-pathway; and (4) uncoupler titrations, while maintaining 
a defined ET-pathway state with constant fuel substrates and inhibitors of specific branches of the ET-
pathway. 
 The three coupling states, ET, LEAK and OXPHOS, are shown schematically with the 
corresponding respiratory rates, abbreviated as E, L and P, respectively (Figure 4). We distinguish 
metabolic pathways from metabolic states and the corresponding metabolic rates; for example: ET-
pathways, ET-states, and ET-capacities, E, respectively (Table 1). The protonmotive force is high in 
the OXPHOS-state when it drives phosphorylation, maximum in the LEAK-state of coupled 
mitochondria, driven by LEAK-respiration at a minimum back-flux of cations to the matrix side, and 
very low in the ET-state when uncouplers short-circuit the proton cycle (Table 1). 
 
Figure 4. Four-compartment 
model of oxidative 
phosphorylation 
Respiratory states (ET, OXPHOS, 
LEAK; Table 1) and corresponding 
rates (E, P, L) are connected by the 
protonmotive force, pmf. (1) ET-
capacity, E, is partitioned into (2) 
dissipative LEAK-respiration, L, 
when the Gibbs energy change of 
catabolic O2 flux is irreversibly lost, 
(3) net OXPHOS-capacity, P-L, with 
partial conservation of the capacity to perform work, and (4) the excess capacity, E-P. Modified from 
Gnaiger (2014). 
Figure 5. Respiratory coupling 
states 
(A) LEAK-state and rate, L: 
Oxidation only, since phosphorylation 
is arrested, JP» = 0, and catabolic O2 
flux, JkO2,L, is controlled mainly by the 
proton leak and slip, JmH+neg, at 
maximum protonmotive force (Figure 
4). Extramitochondrial ATP may be 
hydrolyzed by extramitochondrial 
ATPases, JP«; then phosphorylation 
must be blocked. 
(B) OXPHOS-state and rate, P: 
Oxidation coupled to 
phosphorylation, JP», which is 
stimulated by kinetically-saturating 
[ADP] and [Pi], supported by a high 
protonmotive force. O2 flux, JkO2,P, is 
well-coupled at a P»/O2 flux ratio of 
JP»,P∙JO2,P-1. Extramitochondrial 
ATPases may recycle ATP, JP«.  
(C) ET-state and rate, E: Oxidation 
only, since phosphorylation is zero, 
JP» = 0, at optimum exogenous 
uncoupler concentration when 
noncoupled respiration, JkO2,E, is 
maximum. The F-ATPase may 
hydrolyze extramitochondrial ATP. 
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 2.5.1. LEAK-state (Figure 5A): The LEAK-state is defined as a state of mitochondrial 
respiration when O2 flux mainly compensates for ion leaks in the absence of ATP synthesis, at 
kinetically-saturating concentrations of O2, respiratory fuel substrates and Pi. LEAK-respiration is 
measured to obtain an estimate of intrinsic uncoupling without addition of an experimental uncoupler: 
(1) in the absence of adenylates, i.e., AMP, ADP and ATP; (2) after depletion of ADP at a maximum 
ATP/ADP ratio; or (3) after inhibition of the phosphorylation-pathway by inhibitors of F-ATPase—such 
as oligomycin, or of adenine nucleotide translocase—such as carboxyatractyloside. Adjustment of the 
nominal concentration of these inhibitors to the density of biological sample applied can minimize or 
avoid inhibitory side-effects exerted on ET-capacity or even some dyscoupling. 
 
Table 2. Terms on respiratory coupling and uncoupling. 
Term JkO2 P»/O2 Notes 
acoupled   0 electron transfer in mitochondrial fragments without 
vectorial proton translocation (Figure 3) 
uncoupled L 0 non-phosphorylating LEAK-respiration (Figure 5A) 
proton leak- 
uncoupled 
 0 component of L, H+ diffusion across the mtIM (Figure 
3) 
decoupled   0 component of L, proton slip (Figure 3) 
loosely 
coupled 
 0 component of L, lower coupling due to superoxide 
formation and bypass of proton pumps by electron 
leak (Figure 3) 
dyscoupled   0 pathologically, toxicologically, environmentally 
increased uncoupling, mitochondrial dysfunction  
inducibly 
uncoupled 
 0 by UCP1 or cation (e.g., Ca2+) cycling (Figure 3) 
noncoupled  E 0 ET-capacity, non-phosphorylating respiration 
stimulated to maximum flux at optimum exogenous 
protonophore concentration (Figure 5C) 
well-coupled P high  OXPHOS-capacity, phosphorylating respiration with 
an intrinsic LEAK component (Figure 5B) 
fully coupled P – L max. OXPHOS-capacity corrected for LEAK-respiration 
(Figure 4) 
 
• Proton leak and uncoupled respiration: The intrinsic proton leak is the uncoupled leak current 
of protons in which protons diffuse across the mtIM in the dissipative direction of the downhill 
protonmotive force without coupling to phosphorylation (Figure 5A). The proton leak flux 
depends non-linearly on the protonmotive force (Garlid et al. 1989; Divakaruni and Brand 2011), 
which is a temperature-dependent property of the mtIM and may be enhanced due to possible 
contamination by free fatty acids. Inducible uncoupling mediated by uncoupling protein 1 (UCP1) 
is physiologically controlled, e.g., in brown adipose tissue. UCP1 is a member of the 
mitochondrial carrier family that is involved in the translocation of protons across the mtIM 
(Jezek et al. 2018). Consequently, this short-circuit lowers the protonmotive force and stimulates 
electron transfer, respiration, and heat dissipation in the absence of phosphorylation of ADP. 
• Cation cycling: There can be other cation contributors to leak current including calcium and 
probably magnesium. Calcium influx is balanced by mitochondrial Na+/Ca2+ or H+/Ca2+ 
exchange, which is balanced by Na+/H+ or K+/H+ exchanges. This is another effective uncoupling 
mechanism different from proton leak (Table 2). 
• Proton slip and decoupled respiration: Proton slip is the decoupled process in which protons 
are only partially translocated by a redox proton pump of the ET-pathways and slip back to the 
original vesicular compartment. The proton leak is the dominant contributor to the overall leak 
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current in mammalian mitochondria incubated under physiological conditions at 37 °C, whereas 
proton slip increases at lower experimental temperature (Canton et al. 1995). Proton slip can also 
happen in association with the F-ATPase, in which the proton slips downhill across the pump to 
the matrix without contributing to ATP synthesis. In each case, proton slip is a property of the 
proton pump and increases with the pump turnover rate. 
• Electron leak and loosely coupled respiration: Superoxide production by the ETS leads to a 
bypass of redox proton pumps and correspondingly lower P»/O2 ratio. This depends on the actual 
site of electron leak and the scavenging of hydrogen peroxide by cytochrome c, whereby electrons 
may re-enter the ETS with proton translocation by CIV. 
• Loss of compartmental integrity and acoupled respiration: Electron transfer and catabolic O2 
flux proceed without compartmental proton translocation in disrupted mitochondrial fragments. 
Such fragments are an artefact of mitochondrial isolation, and may not fully fuse to re-establish 
structurally intact mitochondria. Loss of mtIM integrity, therefore, is the cause of acoupled 
respiration, which is a nonvectorial dissipative process without control by the protonmotive force. 
• Dyscoupled respiration: Mitochondrial injuries may lead to dyscoupling as a pathological or 
toxicological cause of uncoupled respiration. Dyscoupling may involve any type of uncoupling 
mechanism, e.g., opening the mtPT pore. Dyscoupled respiration is distinguished from the 
experimentally induced noncoupled respiration in the ET-state (Table 2). 
 
2.5.2. OXPHOS-state (Figure 5B): The OXPHOS-state is defined as the respiratory state with 
kinetically-saturating concentrations of O2, respiratory and phosphorylation substrates, and absence of 
exogenous uncoupler, which provides an estimate of the maximal respiratory capacity in the OXPHOS-
state for any given ET-pathway state. Respiratory capacities at kinetically-saturating substrate 
concentrations provide reference values or upper limits of performance, aiming at the generation of data 
sets for comparative purposes. Physiological activities and effects of substrate kinetics can be evaluated 
relative to the OXPHOS-capacity. 
As discussed previously, 0.2 mM ADP does not kinetically-saturate flux in isolated mitochondria 
(Gnaiger 2001; Puchowicz et al. 2004); greater [ADP] is required, particularly in permeabilized muscle 
fibres and cardiomyocytes, to overcome limitations by intracellular diffusion and by the reduced 
conductance of the mtOM (Jepihhina et al. 2011; Illaste et al. 2012; Simson et al. 2016), either through 
interaction with tubulin (Rostovtseva et al. 2008) or other intracellular structures (Birkedal et al. 2014). 
In addition, kinetically-saturating ADP concentrations need to be evaluated under different experimental 
conditions such as temperature (Lemieux et al. 2017) and with different animal models (Blier and 
Guderley, 1993). In permeabilized muscle fibre bundles of high respiratory capacity, the apparent Km 
for ADP increases up to 0.5 mM (Saks et al. 1998), consistent with experimental evidence that >90% 
kinetic saturation is reached only at >5 mM ADP (Pesta and Gnaiger 2012). Similar ADP concentrations 
are also required for accurate determination of OXPHOS-capacity in human clinical cancer samples and 
permeabilized cells (Klepinin et al. 2016; Koit et al. 2017). 2.5 to 5 mM ADP is sufficient to obtain the 
actual OXPHOS-capacity in many types of permeabilized tissue and cell preparations, but experimental 
validation is required in each specific case. 
2.5.3. Electron transfer-state (Figure 5C): O2 flux determined in the ET-state yields an estimate 
of ET-capacity. The ET-state is defined as the noncoupled state with kinetically-saturating 
concentrations of O2, respiratory substrate and optimum exogenous uncoupler concentration for 
maximum O2 flux. Uncouplers are weak lipid-soluble acids which function as protonophores. These 
disrupt the barrier function of the mtIM and thus short circuit the protonmotive system, functioning like 
a clutch in a mechanical system. As a consequence of the nearly collapsed protonmotive force, the 
driving force is insufficient for phosphorylation, and JP» = 0. The most frequently used uncouplers are 
carbonyl cyanide m-chloro phenyl hydrazone (CCCP), carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP), or dinitrophenol (DNP). Stepwise titration of uncouplers 
stimulates respiration up to or above the level of O2 consumption rates in the OXPHOS-state; respiration 
is inhibited, however, above optimum uncoupler concentrations (Mitchell 2011). Data obtained with a 
single dose of uncoupler must be evaluated with caution, particularly when a fixed uncoupler 
concentration is used in studies exploring a treatment or disease that may alter the mitochondrial content 
or mitochondrial sensitivity to inhibition by uncouplers. There is a need for new protonophoric 
uncouplers that drive maximal respiration across a broad dosing range and do not inhibit respiration at 
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high concentrations (Kenwood et al. 2013). The effect on ET-capacity of the reversed function of F-
ATPase (JP«; Figure 5C) can be evaluated in the presence and absence of extramitochondrial ATP. 
 2.5.4. ROX state and Rox: Besides the three fundamental coupling states of mitochondrial 
preparations, the state of residual O2 consumption, ROX, which although not a coupling state, is relevant 
to assess respiratory function (Figure 1). The rate of residual oxygen consumption, Rox, is defined as 
O2 consumption due to oxidative reactions measured after inhibition of ET with rotenone, malonic acid 
and antimycin A. Cyanide and azide inhibit not only CIV but catalase and several peroxidases involved 
in Rox. High concentrations of antimycin A, but not rotenone or cyanide, inhibit peroxisomal acyl-CoA 
oxidase and D-amino acid oxidase (Vamecq et al. 1987). Rox represents a baseline used to correct 
respiration measured in defined coupling control states. Rox-corrected L, P and E not only lower the 
values of total fluxes, but also change the flux control ratios L/P and L/E. Rox is not necessarily 
equivalent to non-mitochondrial reduction of O2, considering O2-consuming reactions in mitochondria 
that are not related to ET—such as O2 consumption in reactions catalyzed by monoamine oxidases (type 
A and B), monooxygenases (cytochrome P450 monooxygenases), dioxygenase (sulfur dioxygenase and 
trimethyllysine dioxygenase), and several hydoxylases. Even isolated mitochondrial fractions, 
especially those obtained from liver, may be contaminated by peroxisomes, as shown by transmission 
electron microscopy. This fact makes the exact determination of mitochondrial O2 consumption and 
mitochondria-associated generation of reactive oxygen species complicated (Schönfeld et al. 2009; 
Speijer 2016; Figure 2). The dependence of ROX-linked O2 consumption needs to be studied in detail 
together with non-ET enzyme activities, availability of specific substrates, O2 concentration, and 
electron leakage leading to the formation of reactive oxygen species. 
 2.5.5. Quantitative relations: E may exceed or be equal to P. E > P is observed in many types 
of mitochondria, varying between species, tissues and cell types (Gnaiger 2009). E-P is the excess ET-
capacity pushing the phosphorylation-flux (Figure 2C) to the limit of its capacity for utilizing the 
protonmotive force. In addition, the magnitude of E-P depends on the tightness of respiratory coupling 
or degree of uncoupling, since an increase of L causes P to increase towards the limit of E. The excess 
E-P capacity, E-P, therefore, provides a sensitive diagnostic indicator of specific injuries of the 
phosphorylation-pathway, under conditions when E remains constant but P declines relative to controls 
(Figure 4). Substrate cocktails supporting simultaneous convergent electron transfer to the Q-junction 
for reconstitution of TCA cycle function establish pathway control states with high ET-capacity, and 
consequently increase the sensitivity of the E-P assay. 
 E cannot theoretically be lower than P. E < P must be discounted as an artefact, which may be 
caused experimentally by: (1) loss of oxidative capacity during the time course of the respirometric 
assay, since E is measured subsequently to P; (2) using insufficient uncoupler concentrations; (3) using 
high uncoupler concentrations which inhibit ET (Gnaiger 2008); (4) high oligomycin concentrations 
applied for measurement of L before titrations of uncoupler, when oligomycin exerts an inhibitory effect 
on E. On the other hand, the excess ET-capacity is overestimated if kinetically non-saturating [ADP] or 
[Pi] are used. See State 3 in the next section. 
 The net OXPHOS-capacity is calculated by subtracting L from P (Figure 4). The net P»/O2 equals 
P»/(P-L), wherein the dissipative LEAK component in the OXPHOS-state may be overestimated. This 
can be avoided by measuring LEAK-respiration in a state when the protonmotive force is adjusted to its 
slightly lower value in the OXPHOS-state by titration of an ET inhibitor (Divakaruni and Brand 2011). 
Any turnover-dependent components of proton leak and slip, however, are underestimated under these 
conditions (Garlid et al. 1993). In general, it is inappropriate to use the term ATP production or ATP 
turnover for the difference of O2 flux measured in the OXPHOS and LEAK states. P-L is the upper limit 
of OXPHOS-capacity that is freely available for ATP production (corrected for LEAK-respiration) and 
is fully coupled to phosphorylation with a maximum mechanistic stoichiometry (Figure 4). 
 LEAK-respiration and OXPHOS-capacity depend on (1) the tightness of coupling under the 
influence of the respiratory uncoupling mechanisms (Figure 3), and (2) the coupling stoichiometry, 
which varies as a function of the substrate type undergoing oxidation in ET-pathways with either two 
or three coupling sites (Figure 2B). When cocktails with NADH-linked substrates and succinate are 
used, the relative contribution of ET-pathways with three or two coupling sites cannot be controlled 
experimentally, is difficult to determine, and may shift in transitions between LEAK-, OXPHOS- and 
ET-states (Gnaiger 2014). Under these experimental conditions, we cannot separate the tightness of 
coupling versus coupling stoichiometry as the mechanisms of respiratory control in the shift of L/P 
ratios. The tightness of coupling and fully coupled O2 flux, P-L (Table 2), therefore, are obtained from 
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measurements of coupling control of LEAK-respiration, OXPHOS- and ET-capacities in well-defined 
pathway states, using either pyruvate and malate as substrates or the classical succinate and rotenone 
substrate-inhibitor combination (Figure 2B). 
 2.5.6. The steady-state: Mitochondria represent a thermodynamically open system in non-
equilibrium states of biochemical energy transformation. State variables (protonmotive force; redox 
states) and metabolic rates (fluxes) are measured in defined mitochondrial respiratory states. Steady-
states can be obtained only in open systems, in which changes by internal transformations, e.g., O2 
consumption, are instantaneously compensated for by external fluxes across the system boundary, e.g., 
O2 supply, preventing a change of O2 concentration in the system (Gnaiger 1993b). Mitochondrial 
respiratory states monitored in closed systems satisfy the criteria of pseudo-steady states for limited 
periods of time, when changes in the system (concentrations of O2, fuel substrates, ADP, Pi, H+) do not 
exert significant effects on metabolic fluxes (respiration, phosphorylation). Such pseudo-steady states 
require respiratory media with sufficient buffering capacity and substrates maintained at kinetically-
saturating concentrations, and thus depend on the kinetics of the processes under investigation. 
 
2.6. Classical terminology for isolated mitochondria 
‘When a code is familiar enough, it ceases appearing like a code; one forgets that there is a 
decoding mechanism. The message is identical with its meaning’ (Hofstadter 1979). 
 
 Chance and Williams (1955; 1956) introduced five classical states of mitochondrial respiration 
and cytochrome redox states. Table 3 shows a protocol with isolated mitochondria in a closed 
respirometric chamber, defining a sequence of respiratory states. States and rates are not specifically 
distinguished in this nomenclature. 
 
Table 3. Metabolic states of mitochondria (Chance and 
Williams, 1956; Table V). 
 
State 
 
[O2] 
ADP 
level 
Substrate 
  level 
Respiration 
  rate 
Rate-limiting 
  substance 
1 >0 low   low   slow   ADP 
2 >0 high   ~0   slow   substrate 
3 >0 high   high   fast   respiratory chain 
4 >0 low   high   slow   ADP 
5 0 high   high   0   oxygen 
 
 2.6.1. State 1 is obtained after addition of isolated mitochondria to air-saturated 
isoosmotic/isotonic respiration medium containing Pi, but no fuel substrates and no adenylates. 
 2.6.2. State 2 is induced by addition of a ‘high’ concentration of ADP (typically 100 to 300 µM), 
which stimulates respiration transiently on the basis of endogenous fuel substrates and phosphorylates 
only a small portion of the added ADP. State 2 is then obtained at a low respiratory activity limited by 
exhausted endogenous fuel substrate availability (Table 3). If addition of specific inhibitors of 
respiratory complexes such as rotenone does not cause a further decline of O2 flux, State 2 is equivalent 
to the ROX state (See below.). If inhibition is observed, undefined endogenous fuel substrates are a 
confounding factor of pathway control, contributing to the effect of subsequently externally added 
substrates and inhibitors. In contrast to the original protocol, an alternative sequence of titration steps is 
frequently applied, in which the alternative ‘State 2’ has an entirely different meaning when this second 
state is induced by addition of fuel substrate without ADP or ATP (LEAK-state; in contrast to State 2 
defined in Table 1 as a ROX state). Some researchers have called this condition as ‘pseudostate 4’ 
because it has no significant concentrations of adenine nucleotides and hence it is not a near-
physiological condition, although it should be used for calculating the net OXPHOS-capacity, P-L. 
 2.6.3. State 3 is the state stimulated by addition of fuel substrates while the ADP concentration 
is still high (Table 3) and supports coupled energy transformation through oxidative phosphorylation. 
'High ADP' is a concentration of ADP specifically selected to allow the measurement of State 3 to State 
4 transitions of isolated mitochondria in a closed respirometric chamber. Repeated ADP titration re-
establishes State 3 at ‘high ADP’. Starting at O2 concentrations near air-saturation (193 or 238 µM O2 
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at 37 °C or 25 °C and sea level at 1 atm or 101.32 kPa, and an oxygen solubility of respiration medium 
at 0.92 times that of pure water; Forstner and Gnaiger 1983), the total ADP concentration added must 
be low enough (typically 100 to 300 µM) to allow phosphorylation to ATP at a coupled O2 flux that 
does not lead to O2 depletion during the transition to State 4. In contrast, kinetically-saturating ADP 
concentrations usually are 10-fold higher than 'high ADP', e.g., 2.5 mM in isolated mitochondria. The 
abbreviation State 3u is occasionally used in bioenergetics, to indicate the state of respiration after 
titration of an uncoupler, without sufficient emphasis on the fundamental difference between OXPHOS-
capacity (well-coupled with an endogenous uncoupled component) and ET-capacity (noncoupled). 
2.6.4. State 4 is a LEAK-state that is obtained only if the mitochondrial preparation is intact and 
well-coupled. Depletion of ADP by phosphorylation to ATP causes a decline of O2 flux in the transition 
from State 3 to State 4. Under the conditions of State 4, a maximum protonmotive force and high 
ATP/ADP ratio are maintained. The gradual decline of YP»/O2 towards diminishing [ADP] at State 4 must 
be taken into account for calculation of P»/O2 ratios (Gnaiger 2001). State 4 respiration, LT (Table 1), 
reflects intrinsic proton leak and ATP hydrolysis activity. O2 flux in State 4 is an overestimation of 
LEAK-respiration if the contaminating ATP hydrolysis activity recycles some ATP to ADP, JP«, which 
stimulates respiration coupled to phosphorylation, JP» > 0. Some degree of mechanical disruption and 
loss of mitochondrial integrity allows the exposed mitochondrial F-ATPases to hydrolyze the ATP 
synthesized by the fraction of coupled mitochondria. This can be tested by inhibition of the 
phosphorylation-pathway using oligomycin, ensuring that JP» = 0 (State 4o). On the other hand, the State 
4 respiration reached after exhaustion of added ADP is a more physiological condition, i.e., presence of 
ATP, ADP and even AMP. Sequential ADP titrations re-establish State 3, followed by State 3 to State 
4 transitions while sufficient O2 is available. Anoxia may be reached, however, before exhaustion of 
ADP (State 5). 
 2.6.5. State 5 ‘may be obtained by antimycin A treatment or by anaerobiosis’ (Chance and 
Williams, 1955) ‘. These definitions give State 5 two different meanings of ROX or anoxia, respectively. 
Anoxia is obtained after exhaustion of O2 in a closed respirometric chamber. Diffusion of O2 from the 
surroundings into the aqueous solution may be a confounding factor preventing complete anoxia 
(Gnaiger 2001). 
In Table 3, only States 3 and 4 are coupling control states, with the restriction that rates in State 
3 may be limited kinetically by non-saturating ADP concentrations. 
 
2.7. Control and regulation 
 
 The terms metabolic control and regulation are frequently used synonymously, but are 
distinguished in metabolic control analysis: “We could understand the regulation as the mechanism that 
occurs when a system maintains some variable constant over time, in spite of fluctuations in external 
conditions (homeostasis of the internal state). On the other hand, metabolic control is the power to 
change the state of the metabolism in response to an external signal” (Fell 1997). Respiratory control 
may be induced by experimental control signals that exert an influence on: (1) ATP demand and ADP 
phosphorylation-rate; (2) fuel substrate composition, pathway competition; (3) available amounts of 
substrates and O2, e.g., starvation and hypoxia; (4) the protonmotive force, redox states, flux–force 
relationships, coupling and efficiency; (5) Ca2+ and other ions including H+; (6) inhibitors, e.g., nitric 
oxide or intermediary metabolites such as oxaloacetate; (7) signalling pathways and regulatory proteins, 
e.g., insulin resistance, transcription factor hypoxia inducible factor 1.  
 Mechanisms of respiratory control and regulation include adjustments of: (1) enzyme activities 
by allosteric mechanisms and phosphorylation; (2) enzyme content, concentrations of cofactors and 
conserved moieties such as adenylates, nicotinamide adenine dinucleotide [NAD+/NADH], coenzyme 
Q, cytochrome c; (3) metabolic channeling by supercomplexes; and (4) mitochondrial density (enzyme 
concentrations and membrane area) and morphology (cristae folding, fission and fusion). Mitochondria 
are targeted directly by hormones, e.g., progesterone and glucacorticoids, which affect their energy 
metabolism (Lee et al. 2013; Gerö and Szabo 2016; Price and Dai 2016; Moreno et al. 2017; Singh et 
al. 2018). Evolutionary or acquired differences in the genetic and epigenetic basis of mitochondrial 
function (or dysfunction) between individuals; age; biological sex, and hormone concentrations; life 
style including exercise and nutrition; and environmental issues including thermal, atmospheric, toxic 
and pharmacological factors, exert an influence on all control mechanisms listed above. For reviews, 
see Brown 1992; Gnaiger 1993a, 2009; 2014; Paradies et al. 2014; Morrow et al. 2017. 
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 Lack of control by a metabolic pathway, e.g., phosphorylation-pathway, means that there will 
be no response to a variable activating it, e.g., [ADP]. The reverse, however, is not true as the absence 
of a response to [ADP] does not exclude the phosphorylation-pathway from having some degree of 
control. The degree of control of a component of the OXPHOS-pathway on an output variable, such as 
O2 flux, will in general be different from the degree of control on other outputs, such as phosphorylation-
flux or proton leak flux. Therefore, it is necessary to be specific as to which input and output are under 
consideration (Fell 1997). 
 Respiratory control refers to the ability of mitochondria to adjust O2 flux in response to external 
control signals by engaging various mechanisms of control and regulation. Respiratory control is 
monitored in a mitochondrial preparation under conditions defined as respiratory states, preferentially 
under near-physiological conditions of temperature, pH, and medium ionic composition, to generate 
data of higher biological relevance. When phosphorylation of ADP to ATP is stimulated or depressed, 
an increase or decrease is observed in electron transfer measured as O2 flux in respiratory coupling states 
of intact mitochondria (‘controlled states’ in the classical terminology of bioenergetics). Alternatively, 
coupling of electron transfer with phosphorylation is diminished by uncouplers. The corresponding 
coupling control state is characterized by a high respiratory rate without control by P» (noncoupled or 
‘uncontrolled state’). 
 
3. What is a rate? 
 
 The term rate is not adequately defined to be useful for reporting data. Normalization of ‘rates’ 
leads to a diversity of formats. Application of common and defined units is required for direct transfer 
of reported results into a database. The second [s] is the SI unit for the base quantity time. It is also the 
standard time-unit used in solution chemical kinetics. 
 The inconsistency of the meanings of rate becomes apparent when considering Galileo Galilei’s 
famous principle, that ‘bodies of different weight all fall at the same rate (have a constant acceleration)’ 
(Coopersmith 2010). A rate may be an extensive quantity, which is a flow, I, when expressed per object 
(per number of cells or organisms) or per chamber (per system). ‘System’ is defined as the open or 
closed chamber of the measuring device. A rate is a flux, J, when expressed as a size-specific quantity 
(Figure 6A; Box 2). 
• Extensive quantities: An extensive quantity increases proportionally with system size. For 
example, mass and volume are extensive quantities. Flow is an extensive quantity. The 
magnitude of an extensive quantity is completely additive for non-interacting subsystems. 
The magnitude of these quantities depends on the extent or size of the system (Cohen et al. 
2008).  
• Size-specific quantities: ‘The adjective specific before the name of an extensive quantity is 
often used to mean divided by mass’ (Cohen et al. 2008). In this system-paradigm, mass-
specific flux is flow divided by mass of the system (the total mass of everything within the 
measuring chamber or reactor). Rates are frequently expressed as volume-specific flux. A 
mass-specific or volume-specific quantity is independent of the extent of non-interacting 
homogenous subsystems. Tissue-specific quantities (related to the sample in contrast to the 
system) are of fundamental interest in the field of comparative mitochondrial physiology, 
where specific refers to the type of the sample rather than mass of the system. The term 
specific, therefore, must be clarified; sample-specific, e.g., muscle mass-specific 
normalization, is distinguished from system-specific quantities (mass or volume; Figure 6). 
• Intensive quantities: In contrast to size-specific properties, forces are intensive quantities 
defined as the change of an extensive quantity per advancement of an energy transformation 
(Gnaiger 1993b). 
• Formats: The  quantity of a sample X can be expressed in different formats. nX, NX, and mX 
are the molar amount, number, and mass of X, respectively. When different formats are 
indicated in symbols of derived quantities, the format (n, N, m) is shown as a subscript 
(underlined italic), as in IO2/NX and JO2/mX. Oxygen flow and flux are expressed in the molar 
format, nO2 [mol], but in the volume format, VO2 [m3] in ergometry. For mass-specific flux 
these formats can be distinguished as JnO2/mX and JVO2/mX, respectively. Further examples are 
given in Figure 6 and Table 4. 
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Figure 6. Flow and flux, and 
normalization in structure-
function analysis 
(A) When expressing metabolic 
‘rate’ measured in a chamber, a 
fundamental distinction is made 
between relating the rate to the 
experimental sample (left) or 
chamber (right). The different 
meanings of rate need to be 
specified by the chosen 
normalization. Left: Results are 
expressed as mass-specific flux, JmX, 
per mg protein, dry or wet mass. 
Cell volume, Vce, may be used for 
normalization (volume-specific 
flux, JVce). Right: Flow per chamber, 
I, or flux per chamber volume, JV, 
are merely reported for 
methodological reasons.  
(B) O2 flow per cell, IO2/Nce, is the 
product of mitochondria-specific 
flux, mt-density and mass per cell. 
Unstructured analysis: performance 
is the product of mass-specific flux, 
JO2/MX [mol∙s-1∙kg-1], and size (mass 
per cell). Structured analysis: 
performance is the product of 
mitochondrial function (mt-specific 
flux) and structure (mt-content). 
Modified from Gnaiger (2014). For 
further details see Table 4. 
 
 
 
 
 
Box 2: Metabolic flows and fluxes: vectoral, vectorial, and scalar 
 
 In a generalization of electrical terms, flow as an extensive quantity (I; per system) is 
distinguished from flux as a size-specific quantity (J; per system size). Flows, Itr, are defined for all 
transformations as extensive quantities. Electric charge per unit time is electric flow or current, Iel = 
dQel∙dt-1 [A≡ C∙s-1]. When dividing Iel by size of the system (cross-sectional area of a ‘wire’), we obtain 
flux as a size-specific quantity, which is the current density (surface-density of flow) perpendicular to 
the direction of flux, Jel = Iel∙A-1 [A∙m-2] (Cohen et al. 2008). Fluxes with spatial geometric direction and 
magnitude are vectors. Vector and scalar fluxes are related to flows as Jtr = Itr∙A-1 [mol∙s-1∙m-2] and Jtr = 
Itr∙V-1 [mol∙s-1∙m-3], expressing flux as an area-specific vector or volume-specific vectorial or scalar 
quantity, respectively (Gnaiger 1993b). We use the metre–kilogram–second–ampere (MKSA) 
international system of units (SI) for general cases ([m], [kg], [s] and [A]), with decimal SI prefixes for 
specific applications (Table 4). 
 We suggest defining: (1) vectoral fluxes, which are translocations as functions of gradients with 
direction in geometric space in continuous systems; (2) vectorial fluxes, which describe translocations 
in discontinuous systems and are restricted to information on compartmental differences 
(transmembrane proton flux); and (3) scalar fluxes, which are transformations in a homogenous system 
(catabolic O2 flux, JkO2). 
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4. Normalization of rate per sample 
 
 The challenges of measuring mitochondrial respiratory flux are matched by those of 
normalization. Normalization (Table 4) is guided by physicochemical principles, methodological 
considerations, and conceptual strategies (Figure 6). 
 
Table 4. Sample concentrations and normalization of flux. 
Expression Symbol Definition Unit Notes 
Sample     
identity of sample X object: cell, tissue, 
animal, patient 
  
number of sample entities X NX number of objects x  1 
mass of sample X mX  kg  2 
mass of object X MX MX = mX∙NX-1 kg∙x-1 2 
Mitochondria     
mitochondria  mt  X = mt   
amount of  
 mt-elementary components 
 
mtE 
 
quantity of mt-marker 
 
mtEU 
 
Concentrations     
object number concentration CNX CNX = NX∙V-1  x∙m-3 3 
sample mass concentration CmX CmX = mX∙V-1  kg∙m-3  
mitochondrial concentration CmtE CmtE = mtE∙V-1  mtEU∙m-3 4 
specific mitochondrial density DmtE DmtE = mtE∙mX-1  mtEU∙kg-1 5 
mitochondrial content, 
  mtE per object X 
 
mtENX 
 
mtENX = mtE∙NX-1 
 
mtEU∙x-1 
 
6 
O2 flow and flux    7 
flow, system IO2 internal flow mol∙s-1 8 
volume-specific flux JV,O2 JV,O2 = IO2∙V-1 mol∙s-1∙m-3 9 
flow per object X IO2/NX IO2/NX = JV,O2∙CNX-1 mol∙s-1∙x-1 10 
mass-specific flux JO2/mX JO2/mX = JV,O2∙CmX-1 mol∙s-1∙kg-1  
mt-marker-specific flux JO2/mtE JO2/mtE = JV,O2∙CmtE-1 mol∙s-1∙mtEU-1 11 
1 The unit x for a number is not used by IUPAC. To avoid confusion, the units [kg∙x-1] and [kg] 
distinguish the mass per object from the mass of a sample that may contain any number of objects. 
Similarly, the units for flow per system versus flow per object are [mol∙s-1] (Note 8) and [mol∙s-1∙x-1] 
(Note 10). 
2 Units are given in the MKSA system (Box 2). The SI prefix k is used for the SI base unit of mass (kg 
= 1,000 g). In praxis, various SI prefixes are used for convenience, to make numbers easily readable, 
e.g., 1 mg tissue, cell or mitochondrial mass instead of 0.000001 kg. 
3 In case of cells (sample X = cells), the object number concentration is CNce = Nce∙V-1, and volume 
may be expressed in [dm3 ≡ L] or [cm3 = mL]. See Table 5 for different object types. 
4 mt-concentration is an experimental variable, dependent on sample concentration: (1) CmtE = mtE∙V-1; 
(2) CmtE = mtEX∙CNX; (3) CmtE = CmX∙DmtE. 
5 If the amount of mitochondria, mtE, is expressed as mitochondrial mass, then DmtE is the mass 
fraction of mitochondria in the sample. If mtE is expressed as mitochondrial volume, Vmt, and the 
mass of sample, mX, is replaced by volume of sample, VX, then DmtE is the volume fraction of 
mitochondria in the sample. 
6 mtENX = mtE∙NX-1 = CmtE∙CNX-1.  
7 O2 can be replaced by other chemicals to study different reactions, e.g., ATP, H2O2, or vesicular 
compartmental translocations, e.g., Ca2+. 
8 IO2 and V are defined per instrument chamber as a system of constant volume (and constant 
temperature), which may be closed or open. IO2 is abbreviated for IrO2, i.e., the metabolic or internal 
O2 flow of the chemical reaction r in which O2 is consumed, hence the negative stoichiometric 
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number, νO2 = -1. IrO2 = drnO2/dt∙νO2-1. If r includes all chemical reactions in which O2 participates, then 
drnO2 = dnO2 – denO2, where dnO2 is the change in the amount of O2 in the instrument chamber and denO2 
is the amount of O2 added externally to the system. At steady state, by definition dnO2 = 0, hence drnO2 
= –denO2. Note that in this context ‘external’, e, refers to the system, whereas in Figure 1 ‘external’, 
ext, refers to the organism. 
9 JV,O2 is an experimental variable, expressed per volume of the instrument chamber.  
10 IO2/NX is a physiological variable, depending on the size of entity X. 
11 There are many ways to normalize for a mitochondrial marker, that are used in different experimental 
approaches: (1) JO2/mtE = JV,O2∙CmtE-1; (2) JO2/mtE = JV,O2∙CmX-1∙DmtE-1 = JO2/mX∙DmtE-1; (3) JO2/mtE = 
JV,O2∙CNX-1∙mtENX-1 = IO2/NX∙mtENX-1; (4) JO2/mtE = IO2∙mtE-1. The mt-elementary unit [mtEU] varies depending 
on the mt-marker. 
 
 
 
Table 5. Sample types, X, abbreviations, and quantification.  
 
Identity of sample 
 
X 
 
NX 
 
Massa 
 
Volume 
 
mt-Marker 
mitochondrial preparation 
 
 [x] [kg] [m3] [mtEU] 
isolated mitochondria imt  mmt Vmt mtE  
tissue homogenate thom  mthom   mtEthom 
permeabilized tissue pti  mpti  mtEpti 
permeabilized fibre pfi  mpfi  mtEpfi 
permeabilized cell pce Npce Mpce Vpce mtEpce 
cellsb ce Nce Mce Vce mtEce 
intact cell, viable cell vce Nvce Mvce Vvce  
dead cell dce Ndce Mdce Vdce  
organism  org Norg Morg Vorg  
a Instead of mass, the wet weight or dry weight is frequently stated, Ww or Wd. mX is 
mass of the sample [kg], MX is mass of the object [kg∙x-1] (Table 4). 
b Total cell count, Nce = Nvce + Ndce 
 
4.1. Flow: per object 
 
 4.1.1. Number concentration, CNX: Normalization per sample concentration is routinely required 
to report respiratory data. CNX is the experimental number concentration of sample X. In the case of 
animals, e.g., nematodes, CNX = NX∙V-1 [x∙L-1], where NX is the number of organisms in the chamber. 
Similarly, the number of cells per chamber volume is the number concentration of permeabilized or 
intact cells CNce = Nce∙V-1 [x∙L-1], where Nce is the number of cells in the chamber (Table 4). 
 4.1.2. Flow per object, IO2/NX: O2 flow per cell is calculated from volume-specific O2 flux, JV,O2 
[nmol∙s-1∙L-1] (per V of the measurement chamber [L]), divided by the number concentration of cells. 
The total cell count is the sum of viable and dead cells, Nce = Nvce+Ndce (Table 5). The cell viability 
index, VI = Nvce∙Nce-1, is the ratio of viable cells (Nvce; before experimental permeabilization) per total 
cell count. After experimental permeabilization, all cells are permeabilized, Npce = Nce. The cell viability 
index can be used to normalize respiration for the number of cells that have been viable before 
experimental permeabilization, IO2/Nvce = IO2/Nce∙VI-1, considering that mitochondrial respiratory 
dysfunction in dead cells should be eliminated as a confounding factor. 
 The complexity changes when the object is a whole organism studied as an experimental model. 
The scaling law in respiratory physiology reveals a strong interaction between O2 flow and individual 
body mass: basal metabolic rate (flow) does not increase linearly with body mass, whereas maximum 
mass-specific O2 flux, ?̇?O2max or ?̇?O2peak, is approximately constant across a large range of individual 
body mass (Weibel and Hoppeler 2005). Individuals, breeds and species, however, deviate substantially 
from this relationship. ?̇?O2peak of human endurance athletes is 60 to 80 mL O2·min
-1·kg-1 body mass, 
converted to JO2peak/Morg of 45 to 60 nmol·s-1·g-1 (Gnaiger 2014; Table 6). 
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4.2. Size-specific flux: per sample size 
 
 4.2.1. Sample concentration, CmX: Considering permeabilized tissue, homogenate or cells as the 
sample, X, the sample mass is mX [mg], which is frequently measured as wet or dry weight, Ww or Wd 
[mg], respectively, or as amount of protein, mProtein. The sample concentration is the mass of the 
subsample per volume of the measurement chamber, CmX = mX∙V-1 [g∙L-1 = mg∙mL-1]. X is the type of 
sample—isolated mitochondria, tissue homogenate, permeabilized fibres or cells (Table 5). 
 4.2.2. Size-specific flux: Cellular O2 flow can be compared between cells of identical size. To 
take into account changes and differences in cell size, normalization is required to obtain cell size-
specific or mitochondrial marker-specific O2 flux (Renner et al. 2003).  
• Mass-specific flux, JO2/mX [mol∙s-1∙kg-1]: Mass-specific flux is obtained by expressing 
respiration per mass of sample, mX [mg]. Flow per cell is divided by mass per cell, JO2/mce = 
IO2/Nce∙MNce-1. Or chamber volume-specific flux, JV,O2, is divided by mass concentration of X in 
the chamber, JO2/mX = JV,O2∙CmX-1.  
• Cell volume-specific flux, JO2/VX [mol∙s-1∙m-3]: Sample volume-specific flux is obtained by 
expressing respiration per volume of sample. For example, in the case of using cells as sample 
will be the volume of cells added to the chamber (Figure 6). 
 If size-specific O2 flux is constant and independent of sample size, then there is no interaction 
between the subsystems. For example, a 1.5 mg and a 3.0 mg muscle sample respire at identical mass-
specific flux. Mass-specific O2 flux, however, may change with the mass of a tissue sample, cells or 
isolated mitochondria in the measuring chamber, in which case the nature of the interaction becomes an 
issue. Therefore, cell density must be optimized, particularly in experiments carried out in wells, 
considering the confluency of the cell monolayer or clumps of cells (Salabei et al. 2014). 
 
4.3. Marker-specific flux: per mitochondrial content 
 
 Tissues can contain multiple cell populations that may have distinct mitochondrial subtypes. 
Mitochondria undergo dynamic fission and fusion cycles, and can exist in multiple stages and sizes that 
may be altered by a range of factors. The isolation of mitochondria (often achieved through differential 
centrifugation) can therefore yield a subsample of the mitochondrial types present in a tissue, depending 
on the isolation protocols utilized, e.g., centrifugation speed. This possible bias should be taken into 
account when planning experiments using isolated mitochondria. Different sizes of mitochondria are 
enriched at specific centrifugation speeds, which can be used strategically for isolation of mitochondrial 
subpopulations. 
 Part of the mitochondrial content of a tissue is lost during preparation of isolated mitochondria. 
The fraction of isolated mitochondria obtained from a tissue sample is expressed as mitochondrial 
recovery. At a high mitochondrial recovery, the fraction of isolated mitochondria is more representative 
of the total mitochondrial population than in preparations characterized by low recovery. Determination 
of the mitochondrial recovery and yield is based on measurement of the concentration of a mitochondrial 
marker in the stock of isolated mitochondria, CmtE,stock, and crude tissue homogenate, CmtE,thom, which 
simultaneously provides information on the specific mitochondrial density in the sample, DmtE (Table 
4). 
 When discussing concepts of normalization, it is essential to consider the question posed by the 
study. If the study aims at comparing tissue performance—such as the effects of a treatment on a specific 
tissue, then normalization for tissue mass or protein content is appropriate. However, if the aim is to 
find differences in mitochondrial function independent of mitochondrial density (Table 4), then 
normalization to a mitochondrial marker is imperative (Figure 6). One cannot assume that quantitative 
changes in various markers—such as mitochondrial proteins—necessarily occur in parallel with one 
another. It should be established that the marker chosen is not selectively altered by the performed 
treatment. In conclusion, the normalization must reflect the question under investigation to reach a 
satisfying answer. On the other hand, the goal of comparing results across projects and institutions 
requires standardization on normalization for entry into a databank. 
 4.3.1. Mitochondrial concentration, CmtE, and mitochondrial markers: Mitochondrial 
organelles compose a dynamic cellular reticulum in various states of fusion and fission. Hence, the 
definition of an ‘amount’ of mitochondria is often misconceived: mitochondria cannot be counted 
reliably as a number of occurring elementary components. Therefore, quantification of the amount of 
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mitochondria depends on the measurement of chosen mitochondrial markers. “Mitochondria are the 
structural and functional elementary units of cell respiration” (Gnaiger 2014). The quantity of a 
mitochondrial marker can reflect the amount of mitochondrial elementary components, mtE, expressed 
in various mitochondrial elementary units [mtEU] specific for each measured mt-marker (Table 4). 
However, since mitochondrial quality may change in response to stimuli—particularly in mitochondrial 
dysfunction (Campos et al. 2017) and after exercise training (Pesta et al. 2011) and during aging (Daum 
et al. 2013)—some markers can vary while others are unchanged: (1) Mitochondrial volume and 
membrane area are structural markers, whereas mitochondrial protein mass is commonly used as a 
marker for isolated mitochondria. (2) Molecular and enzymatic mitochondrial markers (amounts or 
activities) can be selected as matrix markers, e.g., citrate synthase activity, mtDNA; mtIM-markers, e.g., 
cytochrome c oxidase activity, aa3 content, cardiolipin, or mtOM-markers, e.g., the voltage-dependent 
anion channel (VDAC), TOM20. (3) Extending the measurement of mitochondrial marker enzyme 
activity to mitochondrial pathway capacity, ET- or OXPHOS-capacity can be considered as an 
integrative functional mitochondrial marker. 
 Depending on the type of mitochondrial marker, the mitochondrial elementary component, mtE, 
is expressed in marker-specific units. Mitochondrial concentration in the measurement chamber and the 
tissue of origin are quantified as (1) a quantity for normalization in functional analyses, CmtE, and (2) a 
physiological output that is the result of mitochondrial biogenesis and degradation, DmtE, respectively 
(Table 4). It is recommended, therefore, to distinguish experimental mitochondrial concentration, CmtE 
= mtE∙V-1 and physiological mitochondrial density, DmtE = mtE∙mX-1. Then mitochondrial density is the 
amount of mitochondrial elementary components per mass of tissue, which is a biological variable 
(Figure 6). The experimental variable is mitochondrial density multiplied by sample mass concentration 
in the measuring chamber, CmtE = DmtE∙CmX, or mitochondrial content multiplied by sample number 
concentration, CmtE = mtEX∙CNX (Table 4). 
 4.3.2. mt-Marker-specific flux, JO2/mtE: Volume-specific metabolic O2 flux depends on: (1) the 
sample concentration in the volume of the instrument chamber, CmX, or CNX; (2) the mitochondrial 
density in the sample, DmtE = mtE∙mX-1 or mtEX = mtE∙NX-1; and (3) the specific mitochondrial activity or 
performance per elementary mitochondrial unit, JO2/mtE = JV,O2∙CmtE-1 [mol∙s-1∙mtEU-1] (Table 4). 
Obviously, the numerical results for JO2/mtE vary with the type of mitochondrial marker chosen for 
measurement of mtE and CmtE = mtE∙V-1 [mtEU∙m-3]. 
 Different methods are involved in the quantification of mitochondrial markers and have different 
strengths. Some problems are common for all mitochondrial markers, mtE: (1) Accuracy of 
measurement is crucial, since even a highly accurate and reproducible measurement of O2 flux results 
in an inaccurate and noisy expression if normalized by a biased and noisy measurement of a 
mitochondrial marker. This problem is acute in mitochondrial respiration because the denominators used 
(the mitochondrial markers) are often small moieties of which accurate and precise determination is 
difficult. This problem can be avoided when O2 fluxes measured in substrate-uncoupler-inhibitor 
titration protocols are normalized for flux in a defined respiratory reference state, which is used as an 
internal marker and yields flux control ratios, FCRs. FCRs are independent of externally measured 
markers and, therefore, are statistically robust, considering the limitations of ratios in general (Jasienski 
and Bazzaz 1999). FCRs indicate qualitative changes of mitochondrial respiratory control, with highest 
quantitative resolution, separating the effect of mitochondrial density or concentration on JO2/mX and 
IO2/NX from that of function per elementary mitochondrial marker, JO2/mtE (Pesta et al. 2011; Gnaiger 
2014). (2) If mitochondrial quality does not change and only the amount of mitochondria varies as a 
determinant of mass-specific flux, any marker is equally qualified in principle; then in practice selection 
of the optimum marker depends only on the accuracy and precision of measurement of the mitochondrial 
marker. (3) If mitochondrial flux control ratios change, then there may not be any best mitochondrial 
marker. In general, measurement of multiple mitochondrial markers enables a comparison and 
evaluation of normalization for these mitochondrial markers. Particularly during postnatal development, 
the activity of marker enzymes—such as cytochrome c oxidase and citrate synthase—follows different 
time courses (Drahota et al. 2004). Evaluation of mitochondrial markers in healthy controls is 
insufficient for providing guidelines for application in the diagnosis of pathological states and specific 
treatments. 
 In line with the concept of the respiratory control ratio (Chance and Williams 1955a), the most 
readily used normalization is that of flux control ratios and flux control factors (Gnaiger 2014). Selection 
of the state of maximum flux in a protocol as the reference state has the advantages of: (1) internal 
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normalization; (2) statistically validated linearization of the response in the range of 0 to 1; and (3) 
consideration of maximum flux for integrating a large number of elementary steps in the OXPHOS- or 
ET-pathways. This reduces the risk of selecting a functional marker that is specifically altered by the 
treatment or pathology, yet increases the chance that the highly integrative pathway is disproportionately 
affected, e.g., the OXPHOS- rather than ET-pathway in case of an enzymatic defect in the 
phosphorylation-pathway. In this case, additional information can be obtained by reporting flux control 
ratios based on a reference state that indicates stable tissue-mass specific flux.  
 Stereological measurement of mitochondrial content via two-dimensional transmission electron 
microscopy is considered as the gold standard in determination of mitochondrial volume fractions in 
cells and tissues (Weibel, Hoppeler, 2005). Accurate determination of three-dimensional volume by 
two-dimensional microscopy, however, is both time consuming and statistically challenging (Larsen et 
al. 2012). The validity of using mitochondrial marker enzymes (citrate synthase activity, CI to CIV 
amount or activity) for normalization of flux is limited in part by the same factors that apply to flux 
control ratios. Strong correlations between various mitochondrial markers and citrate synthase activity 
(Reichmann et al. 1985; Boushel et al. 2007; Mogensen et al. 2007) are expected in a specific tissue of 
healthy persons and in disease states not specifically targeting citrate synthase. Citrate synthase activity 
is acutely modifiable by exercise (Tonkonogi et al. 1997; Leek et al. 2001). Evaluation of mitochondrial 
markers related to a selected age and sex cohort cannot be extrapolated to provide recommendations for 
normalization in respirometric diagnosis of disease, in different states of development and ageing, 
different cell types, tissues, and species. mtDNA normalized to nDNA via qPCR is correlated to 
functional mitochondrial markers including OXPHOS- and ET-capacity in some cases (Puntschart et al. 
1995; Wang et al. 1999; Menshikova et al. 2006; Boushel et al. 2007; Ehinger et al. 2015), but lack of 
such correlations have been reported (Menshikova et al. 2005; Schultz and Wiesner 2000; Pesta et al. 
2011). Several studies indicate a strong correlation between cardiolipin content and increase in 
mitochondrial function with exercise (Menshikova et al. 2005; Menshikova et al. 2007; Larsen et al. 
2012; Faber et al. 2014), but it has not been evaluated as a general mitochondrial biomarker in disease. 
With no single best mitochondrial marker, a good strategy is to quantify several different biomarkers to 
minimize the decorrelating effects caused by diseases, treatments, or other factors. Determination of 
multiple markers, particularly a matrix marker and a marker from the mtIM, allows tracking changes in 
mitochondrial quality defined by their ratio. 
 
5. Normalization of rate per system 
 
5.1. Flow: per chamber 
 
 The experimental system (experimental chamber) is part of the measurement instrument, 
separated from the environment as an isolated, closed, open, isothermal or non-isothermal system 
(Table 4). Reporting O2 flows per respiratory chamber, IO2 [nmol∙s-1], restricts the analysis to intra-
experimental comparison of relative differences. 
 
5.2. Flux: per chamber volume 
 
 5.2.1. System-specific flux, JV,O2: We distinguish between (1) the system with volume V and mass 
m defined by the system boundaries, and (2) the sample or objects with volume VX and mass mX that are 
enclosed in the experimental chamber (Figure 6). Metabolic O2 flow per object, IO2/NX, is the total O2 
flow in the system divided by the number of objects, NX, in the system. IO2/NX increases as the mass of 
the object is increased. Sample mass-specific O2 flux, JO2/mX should be independent of the mass of the 
sample studied in the instrument chamber, but system volume-specific O2 flux, JV,O2 (per volume of the 
instrument chamber), increases in proportion to the mass of the sample in the chamber. Although JV,O2 
depends on mass-concentration of the sample in the chamber, it should be independent of the chamber 
(system) volume at constant sample mass-concentration. There are practical limitations to increasing the 
mass-concentration of the sample in the chamber, when one is concerned about crowding effects and 
instrumental time resolution. 
 5.2.2. Advancement per volume: When the reactor volume does not change during the reaction, 
which is typical for liquid phase reactions, the volume-specific flux of a chemical reaction r is the time 
derivative of the advancement of the reaction per unit volume, JV,rB = drξB/dt∙V-1 [(mol∙s-1)∙L-1]. The rate 
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of concentration change is dcB/dt [(mol∙L-1)∙s-1], where concentration is cB = nB∙V-1. There is a difference 
between (1) JV,rO2 [mol∙s-1∙L-1] and (2) rate of concentration change [mol∙L-1∙s-1]. These merge into a 
single expression only in closed systems. In open systems, internal transformations (catabolic flux, O2 
consumption) are distinguished from external flux (such as O2 supply). External fluxes of all substances 
are zero in closed systems. In a closed chamber O2 consumption (internal flux of catabolic reactions k; 
IkO2 [pmol∙s-1]) causes a decline in the amount of O2 in the system, nO2 [nmol]. Normalization of these 
quantities for the volume of the system, V [L ≡ dm3], yields volume-specific O2 flux, JV,kO2 = IkO2/V 
[nmol∙s-1∙L-1], and O2 concentration, [O2] or cO2 = nO2∙V-1 [µmol∙L-1 = µM = nmol∙mL-1]. Instrumental 
background O2 flux is due to external flux into a non-ideal closed respirometer, so total volume-specific 
flux has to be corrected for instrumental background O2 flux—O2 diffusion into or out of the 
instrumental chamber. JV,kO2 is relevant mainly for methodological reasons and should be compared with 
the accuracy of instrumental resolution of background-corrected flux, e.g., ±1 nmol∙s-1∙L-1 (Gnaiger 
2001). ‘Catabolic’ indicates O2 flux, JkO2, corrected for: (1) instrumental background O2 flux; (2) 
chemical background O2 flux due to autoxidation of chemical components added to the incubation 
medium; and (3) Rox for O2-consuming side reactions unrelated to the catabolic pathway k. 
 
6. Conversion of units 
 
 Many different units have been used to report the O2 consumption rate, OCR (Table 6). SI base 
units provide the common reference to introduce the theoretical principles (Figure 6), and are used with 
appropriately chosen SI prefixes to express numerical data in the most practical format, with an effort 
towards unification within specific areas of application (Table 7). Reporting data in SI units—including 
the mole [mol], coulomb [C], joule [J], and second [s]—should be encouraged, particularly by journals 
that propose the use of SI units. 
 
Table 6. Conversion of various formats and units used in respirometry and 
ergometry. e- is the number of electrons or reducing equivalents. zB is the charge number 
of entity B. 
Format 1 Unit                                   ∙ Multiplication factor SI-unit  Notes 
n  ng.atom O∙s-1 (2 e-) 0.5 nmol O2∙s-1  
n  ng.atom O∙min-1 (2 e-) 8.33 pmol O2∙s-1  
n  natom O∙min-1 (2 e-) 8.33 pmol O2∙s-1  
n  nmol O2∙min-1 (4 e-) 16.67 pmol O2∙s-1  
n  nmol O2∙h-1 (4 e-) 0.2778 pmol O2∙s-1  
V to n mL O2∙min-1 at STPD
a 0.744 µmol O2∙s-1 1 
e to n W = J/s at -470 kJ/mol O2 -2.128 µmol O2∙s-1  
e to n mA = mC∙s-1  (zH+ = 1) 10.36 nmol H+∙s-1 2 
e to n mA = mC∙s-1  (zO2 = 4) 2.59 nmol O2∙s-1 2 
n to e nmol H+∙s-1  (zH+ = 1) 0.09649 mA 3 
n to e nmol O2∙s-1  (zO2 = 4) 0.38594 mA 3 
1 At standard temperature and pressure dry (STPD: 0 °C = 273.15 K and 1 atm = 101.325 kPa = 
760 mmHg), the molar volume of an ideal gas, Vm, and Vm,O2 is 22.414 and 22.392 L∙mol-1, 
respectively. Rounded to three decimal places, both values yield the conversion factor of 0.744. 
For comparison at normal temperature and pressure dry (NTPD: 20 °C), Vm,O2 is 24.038 L∙mol-1. 
Note that the SI standard pressure is 100 kPa. 
2 The multiplication factor is 106/(zB∙F). 
3 The multiplication factor is zB∙F/106. 
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Table 7. Conversion of units with preservation of numerical values. 
Name Frequently used unit Equivalent unit Notes 
volume-specific flux, JV,O2 pmol∙s-1∙mL-1 nmol∙s-1∙L-1 1 
 mmol∙s-1∙L-1 mol∙s-1∙m-3  
cell-specific flow, IO2/cell pmol∙s-1∙10-6 cells amol∙s-1∙cell-1 2 
 pmol∙s-1∙10-9 cells zmol∙s-1∙cell-1 3 
cell number concentration, CNce  106 cells∙mL-1 109 cells∙L-1  
mitochondrial protein concentration, CmtE 0.1 mg∙mL-1 0.1 g∙L-1  
mass-specific flux, JO2/m pmol∙s-1∙mg-1 nmol∙s-1∙g-1 4 
catabolic power, Pk µW∙10-6 cells pW∙cell-1 1 
volume  1,000 L m3 (1,000 kg)  
 L dm3 (kg)  
 mL cm3 (g)  
 µL mm3 (mg)  
 fL µm3 (pg) 5 
amount of substance concentration M = mol∙L-1 mol∙dm-3  
1 pmol: picomole = 10-12 mol 4 nmol: nanomole = 10-9 mol 
2 amol: attomole = 10-18 mol 5 fL: femtolitre = 10-15 L 
3 zmol: zeptomole = 10-21 mol  
 
 Although volume is expressed as m3 using the SI base unit, the litre [dm3] is a conventional unit 
of volume for concentration and is used for most solution chemical kinetics. If one multiplies IO2/Nce by 
CNce, then the result will not only be the amount of O2 [mol] consumed per time [s-1] in one litre [L-1], 
but also the change in O2 concentration per second (for any volume of an ideally closed system). This 
is ideal for kinetic modeling as it blends with chemical rate equations where concentrations are typically 
expressed in mol∙L-1 (Wagner et al. 2011). In studies of multinuclear cells—such as differentiated 
skeletal muscle cells—it is easy to determine the number of nuclei but not the total number of cells. A 
generalized concept, therefore, is obtained by substituting cells by nuclei as the sample entity. This does 
not hold, however, for non-nucleated platelets. 
 For studies of cells, we recommend that respiration be expressed, as far as possible, as: (1) O2 
flux normalized for a mitochondrial marker, for separation of the effects of mitochondrial quality and 
content on cell respiration (this includes FCRs as a normalization for a functional mitochondrial 
marker); (2) O2 flux in units of cell volume or mass, for comparison of respiration of cells with different 
cell size (Renner et al. 2003) and with studies on tissue preparations, and (3) O2 flow in units of attomole 
(10-18 mol) of O2 consumed per second by each cell [amol∙s-1∙cell-1], numerically equivalent to 
[pmol∙s-1∙10-6 cells]. This convention allows information to be easily used when designing experiments 
in which O2 flow must be considered. For example, to estimate the volume-specific O2 flux in an 
instrument chamber that would be expected at a particular cell number concentration, one simply needs 
to multiply the flow per cell by the number of cells per volume of interest. This provides the amount of 
O2 [mol] consumed per time [s-1] per unit volume [L-1]. At an O2 flow of 100 amol∙s-1∙cell-1 and a cell 
density of 109 cells∙L-1 (106 cells∙mL-1), the volume-specific O2 flux is 100 nmol∙s-1∙L-1 (100 
pmol∙s-1∙mL-1). 
 ET-capacity in human cell types including HEK 293, primary HUVEC, and fibroblasts ranges 
from 50 to 180 amol∙s-1∙cell-1, measured in intact cells in the noncoupled state (see Gnaiger 2014). At 
100 amol∙s-1∙cell-1 corrected for Rox, the current across the mt-membranes, IH+e, approximates 193 
pA∙cell-1 or 0.2 nA per cell. See Rich (2003) for an extension of quantitative bioenergetics from the 
molecular to the human scale, with a transmembrane proton flux equivalent to 520 A in an adult at a 
catabolic power of -110 W. Modelling approaches illustrate the link between protonmotive force and 
currents (Willis et al. 2016). 
 We consider isolated mitochondria as powerhouses and proton pumps as molecular machines to 
relate experimental results to energy metabolism of the intact cell. The cellular P»/O2 based on oxidation 
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of glycogen is increased by the glycolytic (fermentative) substrate-level phosphorylation of 3 P»/Glyc 
or 0.5 mol P» for each mol O2 consumed in the complete oxidation of a mol glycosyl unit (Glyc). Adding 
0.5 to the mitochondrial P»/O2 ratio of 5.4 yields a bioenergetic cell physiological P»/O2 ratio close to 
6. Two NADH equivalents are formed during glycolysis and transported from the cytosol into the 
mitochondrial matrix, either by the malate-aspartate shuttle or by the glycerophosphate shuttle (Figure 
2A) resulting in different theoretical yields of ATP generated by mitochondria, the energetic cost of 
which potentially must be taken into account. Considering also substrate-level phosphorylation in the 
TCA cycle, this high P»/O2 ratio not only reflects proton translocation and OXPHOS studied in isolation, 
but integrates mitochondrial physiology with energy transformation in the living cell (Gnaiger 1993a). 
 
7. Conclusions 
 
 Catabolic cell respiration is the process of exergonic and exothermic energy transformation in 
which scalar redox reactions are coupled to vectorial ion translocation across a semipermeable 
membrane, which separates the small volume of a bacterial cell or mitochondrion from the larger volume 
of its surroundings. The electrochemical exergy can be partially conserved in the phosphorylation of 
ADP to ATP or in ion pumping, or dissipated in an electrochemical short-circuit. Respiration is thus 
clearly distinguished from fermentation as the counterparts of cellular core energy metabolism. An O2 
flux balance scheme illustrates the relationships and general definitions (Figures 1 and 2). 
 
Box 3: Recommendations for studies with mitochondrial preparations 
 
● Normalization of respiratory rates should be provided as far as possible:  
 A. Sample normalization 
 1.  Object-specific biophysical normalization: on a per organism or per cell basis as O2 
flow; this may not be possible when dealing with coenocytic organisms, e.g., 
filamentous fungi, or tissues without cross-walls separating individual cells, e.g., 
muscle fibers. 
 2. Size-specific cellular normalization: per g protein; per organism-, cell- or tissue-mass 
as mass-specific O2 flux; per cell volume as cell volume-specific flux. 
 3. Mitochondrial normalization: per mitochondrial marker as mt-specific flux.  
 B. Chamber normalization 
 1.  Chamber volume-specific flux, JV [pmol∙s-1∙mL-1], is reported for quality control in 
relation to instrumental sensitivity and limit of detection of volume-specific flux. 
 2. Sample concentration in the instrumental chamber is reported as number concentration, 
mass concentration, or mitochondrial concentration; this is a component of the 
measuring conditions. 
 With information on cell size and the use of multiple normalizations, maximum potential information 
is available (Renner et al. 2003; Wagner et al. 2011; Gnaiger 2014). Reporting flow in a respiratory 
chamber [nmol∙s-1] is discouraged, since it restricts the analysis to intra-experimental comparison of 
relative (qualitative) differences. 
● Catabolic mitochondrial respiration is distinguished from residual O2 consumption. Fluxes in 
mitochondrial coupling states should be, as far as possible, corrected for residual O2 consumption. 
● Different mechanisms of uncoupling should be distinguished by defined terms. The tightness of 
coupling relates to these uncoupling mechanisms, whereas the coupling stoichiometry varies as a 
function the substrate type involved in ET-pathways with either three or two redox proton pumps 
operating in series. Separation of tightness of coupling from the pathway-dependent coupling 
stoichiometry is possible only when the substrate type undergoing oxidation remains the same for 
respiration in LEAK-, OXPHOS-, and ET-states. In studies of the tightness of coupling, therefore, 
simple substrate-inhibitor combinations should be applied to exlcude a shift in substrate competition 
that may occur when providing physiological substrate cocktails. 
● In studies of isolated mitochondria, the mitochondrial recovery and yield should be reported. 
Experimental criteria such as transmission electron microscopy for evaluation of purity versus 
integrity should be considered. Mitochondrial markers—such as citrate synthase activity as an 
enzymatic matrix marker—provide a link to the tissue of origin on the basis of calculating the 
mitochondrial recovery, i.e., the fraction of mitochondrial marker obtained from a unit mass of tissue. 
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Total mitochondrial protein is frequently applied as a mitochondrial marker, which is restricted to 
isolated mitochondria. 
● In studies of permeabilized cells, the viability of the cell culture or cell suspension of origin should 
be reported. Normalization should be evaluated for total cell count or viable cell count. 
● Terms and symbols are summarized in Table 8. Their use will facilitate transdisciplinary 
communication and support further development of a consistent theory of bioenergetics and 
mitochondrial physiology. Technical terms related to and defined with normal words can be used as 
index terms in databases, support the creation of ontologies towards semantic information processing 
(MitoPedia), and help in communicating analytical findings as impactful data-driven stories. 
‘Making data available without making it understandable may be worse than not making it available 
at all’ (National Academies of Sciences, Engineering, and Medicine 2018). Success will depend on 
taking further steps: (1) exhaustive text-mining considering Omics data and functional data; (2) 
network analysis of Omics data with bioinformatics tools; (3) cross-validation with distinct 
bioinformatics approaches; (4) correlation with functional data; (5) guidelines for biological 
validation of network data. This is a call to carefully contribute to FAIR principles (Findable, 
Accessible, Interoperable, Reusable) for the sharing of scientific data. 
 
 
 
Table 8. Terms, symbols, and units. 
 
 
Term Symbol Unit  Links and comments 
 
 
alternative quinol oxidase AOX  Figure 2B 
adenosine monophosphate AMP  2 ADP ↔ ATP+AMP 
adenosine diphosphate ADP  Table 1; Figures 1, 2 and 5 
adenosine triphosphate ATP  Figures 2 and 5 
adenylates AMP, ADP, ATP Section 2.5.1 
amount of substance B nB [mol]  
ATP yield per O2 YP»/O2  P»/O2 ratio measured in any 
respiratory state 
catabolic reaction k  Figures 1 and 3 
catabolic respiration JkO2 varies Figures 1 and 3 
cell respiration JrO2 varies Figure 1 
cell viability index VI  VI = Nvce∙Nce-1 = 1- Ndce∙Nce-1 
charge number of entity B zB  Table 6; zO2 = 4 
Complexes I to IV CI to CIV  respiratory ET Complexes; Figure 
2B 
concentration of substance B cB = nB∙V-1; [B] [mol∙m-3]  Box 2 
coupling control state CCS  Section 2.4.1 
dead cell number Ndce [x] non-viable cells, loss of plasma 
membrane barrier function; Table 5 
electric format e [C] Table 6 
electron transfer system ETS  state; Figures 2B and 4 
ET state ET  Table 1; Figures 2B and 4; State 3u 
ET-capacity E varies Table 1; Figure 4 
flow, for substance B IB [mol∙s-1]  system-related extensive quantity; 
Figure 6 
flux, for substance B JB varies size-specific quantitiy; Figure 6 
inorganic phosphate Pi  Figure 2C 
inorganic phosphate carrier PiC  Figure 2C 
intact cell number,  
viable cell number Nvce [x] viable cells, intact plasma membrane 
barrier function; Table 5 
LEAK state  LEAK  state; Table 1; Figure 4; compare 
State 4 
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LEAK-respiration L varies Table 1; Figure 4 
mass format m [kg] Table 4; Figure 6 
mass of sample X mX [kg]  Table 4 
mass, dry mass md [kg] mass of sample X; Figure 6 
(frequently called dry weight) 
mass, wet mass mw [kg] mass of sample X; Figure 6 
(frequently called wet weight) 
mass of object X MX = mX∙NX-1 [kg∙x-1]  mass of entity X; Table 4 
MITOCARTA         https://www.broadinstitute.org/scientific-
community/science/programs/metabol
ic-disease-
program/publications/mitocarta/mitoc
arta-in-0  
MitoPedia        http://www.bioblast.at/index.php/MitoPedia 
mitochondria or mitochondrial mt  Box 1 
mitochondrial DNA mtDNA  Box 1 
mitochondrial concentration CmtE = mtE∙V-1  [mtEU∙m-3]  Table 4 
mitochondrial content mtEX  [mtEU∙x-1]  mtEX = mtE∙NX-1; Table 4 
mitochondrial  
elementary component mtE [mtEU] quantity of mt-marker; Table 4 
mitochondrial elementary unit mtEU varies  specific units for mt-marker; Table 4  
mitochondrial inner membrane  mtIM   MIM is widely used; the first M is 
replaced by mt; Figure 2; Box 1 
mitochondrial outer membrane  mtOM   MOM is widely used; the first M is 
replaced by mt; Figure 2; Box 1 
mitochondrial recovery YmtE  fraction of mtE recovered in sample 
from the tissue of origin 
mitochondrial yield YmtE/m  mt-yield per tissues mass; YmtE/m = 
YmtE ∙ DmtE 
molar format n [mol] Table 6 
negative neg  Figure 4 
number concentration of X CNX [x∙m-3]  Table 4 
number format N [x] Table 4; Figure 6 
number of cells Nce [x] Nce = Nvce + Ndce; Table 5 
number of entities X NX [x]  Table 4; Figure 6 
number of entity B NB [x] Table 4 
oxidative phosphorylation OXPHOS  state; Table 1; Figure 4 
OXPHOS state OXPHOS  Table 1; State 3 if [ADP] and [Pi] 
are kinetically-saturating 
OXPHOS-capacity P varies Table 1; Figure 4 
oxygen concentration cO2 = nO2∙V-1 [mol∙m-3]  [O2]; Section 3.2 
oxygen flux, in reaction r JrO2 varies Figure 1 
pathway control state PCS  Section 2.2 
permeability transition mtPT  Figure 3; Section 2.4.3; MPT is 
widely used; M is replaced by mt 
permeabilized cell number Npce [x] experimental permeabilization of 
plasma membrane; Table 5 
phosphorylation of ADP to ATP P»  Section 2.2 
P»/O2 ratio P»/O2   mechanistic YP»/O2, calculated from 
pump stoichiometries; Figure 2B 
positive pos  Figure 4 
proton in the negative compartment H+neg  Figure 4 
proton in the positive compartment H+pos  Figure 4 
protonmotive force pmf [V] Figures 1, 2A and 4; Table 1 
rate of electron transfer in ET state E varies ET-capacity; Table 1 
rate of LEAK-respiration L varies Table 1: L(n), L(T), L(Omy) 
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rate of oxidative phosphorylation P varies OXPHOS-capacity; Table 1 
rate of residual oxygen consumption Rox  Table 1; Figure 1 
residual oxygen consumption ROX; Rox  state ROX; rate Rox; Table 1 
respiratory supercomplex SC InIIInIVn   supramolecular assemblies 
composed of variable copy numbers 
(n) of CI, CIII and CIV; Box 1 
specific mitochondrial density DmtE = mtE∙mX-1 [mtEU∙kg-1] Table 4 
substrate concentration at  
half-maximal rate c50 [mol∙m-3] Section 2.1.2 
substrate-uncoupler-inhibitor- 
titration protocol SUIT  Section 2.2 
volume V [m-3] Table 7 
volume format V [m-3] Table 6 
 
 
 Experimentally, respiration is separated in mitochondrial preparations from the interactions with 
the fermentative pathways of the intact cell. OXPHOS analysis is based on the study of mitochondrial 
preparations complementary to bioenergetic investigations of (1) submitochondrial particles and 
molecular structures, (2) intact cells, and (3) organisms—from model organisms to the human species 
including healthy and diseased persons (patients). Different mechanisms of respiratory uncoupling have 
to be distinguished (Figure 3). Metabolic fluxes measured in defined coupling and pathway control 
states (Figures 5 and 6) provide insights into the meaning of cellular and organismic respiration.  
 The optimal choice for expressing mitochondrial and cell respiration as O2 flow per biological 
sample, and normalization for specific tissue-markers (volume, mass, protein) and mitochondrial 
markers (volume, protein, content, mtDNA, activity of marker enzymes, respiratory reference state) is 
guided by the scientific question under study. Interpretation of the data depends critically on appropriate 
normalization (Figure 6).  
 MitoEAGLE can serve as a gateway to better diagnose mitochondrial respiratory adaptations and 
defects linked to genetic variation, age-related health risks, sex-specific mitochondrial performance, 
lifestyle with its effects on degenerative diseases, and thermal and chemical environment. The present 
recommendations on coupling control states and rates, linked to the concept of the protonmotive force, 
are focused on studies using mitochondrial preparations (Box 3). These will be extended in a series of 
reports on pathway control of mitochondrial respiration, respiratory states in intact cells, and 
harmonization of experimental procedures. 
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Supplement 
 
S1. Manuscript phases and versions - an open-access apporach 
 
This manuscript on ‘Mitochondrial respiratory states and rates’ is a position statement in the frame of COST Action 
CA15203 MitoEAGLE. The global MitoEAGLE network made it possible to collaborate with a large number of 
coauthors to reach consensus on the present manuscript. Nevertheless, we do not consider scientific progress to be 
supported by ‘declaration’ statements (other than on ethical or political issues). Our manuscript aims at providing 
arguments for further debate rather than pushing opinions. We hope to initiate a much broader process of 
discussion and want to raise the awareness of the importance of a consistent terminology for reporting of scientific 
data in the field of bioenergetics, mitochondrial physiology and pathology. Quality of research requires quality of 
communication. Some established researchers in the field may not want to re-consider the use of jargon which has 
become established despite deficiencies of accuracy and meaning. In the long run, superior standards will become 
accepted. We hope to contribute to this evolutionary process, with an emphasis on harmonization rather than 
standardization. 
Phase 1 The protonmotive force and respiratory control 
 http://www.mitoeagle.org/index.php/The_protonmotive_force_and_respiratory_control  
• 2017-04-09 to 2017-09-18 (44 versions) / 2017-09-21 to 2018-02-06 (44 plus 21 versions) 
http://www.mitoeagle.org/index.php/MitoEAGLE_preprint_2017-09-21  
2017-11-11: Print version (16) for MiP2017/MitoEAGLE conference in Hradec Kralove  
Phase 2 Mitochondrial respiratory states and rates: Building blocks of mitochondrial physiology Part 1 
 http://www.mitoeagle.org/index.php/MitoEAGLE_preprint_States_and_rates   
• 2018-02-08 – 2019-01-24 (44 plus 52 traceable Versions)  
Phase 3 2019-02-12 Preprint DOI number doi:10.26124/mitofit:190001, providing widely accepted visible proof 
that the publication is citable 
 2019-03-15 Version 2: doi:10.26124/mitofit:190001.v2 
Phase 4 Journal submission 
 
S2. Joining COST Actions 
 
• CA15203 MitoEAGLE - http://www.cost.eu/COST_Actions/ca/CA15203  
• CA16225 EU-CARDIOPROTECTION - http://www.cost.eu/COST_Actions/ca/CA16225  
• CA17129 CardioRNA - http://www.cost.eu/COST_Actions/ca/CA17129  
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S3. COST Action CA15203 MitoEAGLE 
 
 
 
Evolution Age Gender 
Lifestyle Environment 
 
 
Mission of the global MitoEAGLE network  
in collaboration with the Mitochondrial Physiology Society, MiPs 
 
• Improve our knowledge on 
mitochondrial function in 
health and disease with regard 
to Evolution, Age, Gender, 
Lifestyle and Environment 
 
• Interrelate studies across 
laboratories with the help of a 
MitoEAGLE data management 
system 
 
• Provide standardized measures 
to link mitochondrial and 
physiological performance to understand the myriad of factors that play a role in 
mitochondrial physiology 
 
 
Join the COST Action MitoEAGLE - contribute to the quality management network. 
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